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Patent-Antitrust Interface
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This Article proposes a new approach, the constrained maximization approach, to the
patent-antitrust interface. It advocates a return to the utilitarian premise of the patent
system, which posits that innovation incentives are preserved so long as the costs of
innovation are recovered. While this premise is widely accepted, it is seldom applied by
the courts in patent-antitrust cases. The result is that courts and commentators have
been overly deferential to dynamic efficiency arguments in defense of patent exploitation
practices, and have failed to scrutinize the extent to which patentee reward is genuinely
essential to generating innovation incentives. Under the constrained maximization
approach, the antitrust courts attempt to maximize the net social benefits of an innovation
by adjusting the scope of patent exploitation, subject to the constraint that innovation
costs are recouped. This approach will allow the courts to take into account two
important considerations in the balance between static and dynamic efficiencies that
have been largely overlooked: the contribution of cumulative innovation to social welfare
and the variety of ways in which innovators recover their R&D investments in addition to
patent protection. Incorporation of both of these considerations lends support to a more
robust approach to the patent-antitrust interface.
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INTRODUCTION
¶1

The patent-antitrust interface is probably the area of antitrust law that has received
the most academic attention in recent years.1 With its juxtaposition of patent policy with
antitrust policy, it is generally perceived to be one of the most intricate areas of antitrust.
In fact, to the best of this author’s knowledge, it is the only area on which a separate
treatise has been published.2 To the extent that patent policy and antitrust policy conflict
over the assessment of the legality of a patent exploitation practice, the courts must
balance antitrust concerns about static efficiency and consumer welfare with the dynamic
efficiency considerations of patent law. Any area of antitrust that requires balancing is,
by nature, complicated. A balancing exercise that requires consideration of the policy of
another body of law is yet more complex.

1

For a sample of this vast body of literature, see William Baxter, Legal Restrictions on Exploitation of
the Patent Monopoly: An Economic Analysis, 76 YALE L. J. 267 (1966); WARD BOWMAN, PATENT AND
ANTITRUST LAW (1973); Louis Kaplow, The Patent-Antitrust Intersection: A Reappraisal, 97 HARV. L.
REV. 1813 (1984); Willard K. Tom & Joshua A. Newberg, Antitrust and Intellectual Property: From
Separate Spheres to Unified Field, 66 Antitrust L. J. 167 (1997); Michael A. Carrier, Unraveling the
Patent-Antitrust Paradox, 150 U. PENN. L. REV. 761 (2002); ANTITRUST, PATENTS AND COPYRIGHT: EU
AND US PERSPECTIVES (François Lévêque & Howard Shelanski eds., 2005); THE INTERFACE BETWEEN
INTELLECTUAL PROPERTY RIGHTS AND COMPETITION POLICY (Steven D. Anderman ed., 2007); Daniel A.
Crane, Intellectual Liability, 88 TEX. L. REV. 253, 254 (2009); MICHAEL A. CARRIER, INNOVATION FOR THE
21ST CENTURY (2009); Josef Drexl, Real Knowledge is to Know the Extent of One’s Own Ignorance: On the
Consumer Harm Approach in Innovation-Related Competition Cases, 76 ANTITRUST L. J. 677 (2010).
2
HERBERT HOVENKAMP ET AL., IP AND ANTITRUST: AN ANALYSIS OF ANTITRUST PRINCIPLES APPLIED
TO INTELLECTUAL PROPERTY LAW (2010).
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The standard argument concerning the patent-antitrust interface is as follows: the
patent system provides incentives for innovation by granting the innovator a period of
exclusivity, during which he or she may be able to charge a supra-competitive price for
its technology or for products incorporating this technology. The result of this
exclusivity is that consumers will have to bear a higher price. It is this supernormal profit
that is said to allow innovators to recover the costs of innovation. R&D costs are
generally thought of as sunk costs. Without patent protection, competitors will be able to
imitate the technology quickly and cheaply, driving the price to its marginal costs, which
of course exclude sunk costs. Assuming that the marginal costs of production are
constant,3 the innovator will be denied recovery of its R&D costs. Innovation will hence
be deterred. To remedy this unsatisfactory state of affairs, the patent system grants the
innovator the right to exclude and a host of other patent rights. These rights and the
patentee reward that they help to generate are crucial to attract innovators, supplying
them sufficient financial incentives to pursue R&D. Since innovation is the engine of
growth in the modern-day economy, innovation should be encouraged as much as
possible. The common belief is that more innovation is better for society. Under this
tenet, antitrust policy should defer to patent policy unless there is persuasive evidence of
certain consumer harm, perhaps as in the case of price fixing.4
The courts often seem all too willing to accept this standard argument and uphold
patent exploitation practices. This is in no small part due to a perception that dynamic
efficiency arguments are difficult to verify. While the courts are ready to challenge
claims of short-run consumer harm, they have largely withheld scrutiny from arguments
asserting reduction of innovation incentives. When a defendant makes a credible claim
that a certain patent exploitation practice is essential to generating sufficient patentee
reward, which in turn is essential to securing adequate innovation incentives, the courts
are generally reluctant to examine to what extent the exploitation practice at issue is
genuinely essential to the recovery of innovation costs. They are equally reluctant, if not
even more so, to question whether patentee reward in general is necessary for attracting
innovation. Claims of the deterrence of future innovation are even less susceptible to
refutation, perhaps because they are by and large empirically unverifiable. Dynamic
efficiency arguments at times have come to be treated as a trump card in patent-antitrust
cases.5
The goal of this Article is to show that for the courts to attain a more balanced view
of the patent-antitrust interface, they must begin to scrutinize dynamic efficiency
arguments. Claims about harm to innovation incentives should not be accepted at face
value. In particular, this Article will attempt to refocus attention on the fundamental
premise of the patent system that innovators will have sufficient incentives to innovate as
3

This assumption is important because if marginal costs are rising, the innovator will be able to recover
at least part of the R&D costs from the sale of the initial units. Since the equilibrium price is determined by
the marginal costs of the last unit being sold, and the marginal costs of that unit will be higher than those of
the infra-marginal ones under an assumption of rising marginal costs, the equilibrium price will necessarily
exceed the marginal costs of the infra-marginal units, allowing the innovator to recover part of its R&D
costs.
4
In the 1926 General Electric case, the Supreme Court seemed to have suggested that antitrust policy
yields even in the presence of such conduct. See United States v. Gen. Elec. Co., 272 U.S. 476, 47 S.Ct.
192 (1926).
5
CSU v. Xerox Corp., 203 F.3d 1322 (Fed Cir. 2000); United States v. Microsoft Corp., 253 F.3d 34
(D.C. Cir. 2001).
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long as their innovation costs are fully compensated. The reward offered by the patent
system is not closely calibrated to match innovation costs. Hence the scope of rights
permitted by the current patent system may significantly exceed that which is necessary
to generate innovation.
The argument that patent rights must be respected to preserve innovation incentives
is hence not universally valid. In fact, there are reasons to believe that it is not so in
many instances. This is especially true once one takes into account the various
alternative ways in which the innovator can appropriate the benefits of its creation
without the assistance of patents. As will be explained subsequently, there are a myriad
of ways that have been found to be even more effective than patent protection in securing
private returns to innovation. Incorporating these observations about innovation
incentives, this Article proposes a “constrained maximization” approach to the patentantitrust interface, under which the courts attempt to maximize the net social benefits of
an innovation subject to the constraint that the private benefits of innovation, which
include patentee reward and returns from other means of appropriation, must cover
innovation costs. Drawing on insights from this approach, this Article will then provide
practical guidance on how to decide patent-antitrust cases by focusing on the various
attributes of innovation.
This Article is divided into five sections. Section I provides an overview of the
policy conflict underlying the patent-antitrust interface and a critical examination of some
of the approaches that have been proposed to resolve it. Section II examines the
theoretical justifications for patent protection and the implications they have for the
patent-antitrust interface. In particular, it will be argued that the current assumption
about the imperative of preserving patentee reward often leads to timid enforcement
against harmful patent exploitation practices. Section III attempts to bring the theoretical
discussion in Section II to a more practical level and offers concrete suggestions on how
to apply the lessons drawn from the previous Section in actual cases. Section IV
illustrates the application of the approach proposed in this Article by applying it to refusal
to license cases. Section V concludes the Article.
I. CONFLICT BETWEEN PATENT LAW AND ANTITRUST—APPARENT OR REAL?
A. Short-Run Conflict Between Patent and Antitrust

¶7

The goal of antitrust is to promote consumer welfare by fostering competition on
the merits and preventing firms from deploying anticompetitive practices to exclude
rivals and inflict harm on consumers. Consumer welfare is enhanced when consumers
are able to obtain the same good at a lower price or obtain a higher-quality good at the
same price. Consumer welfare is also improved when consumer choice is widened. In
economic parlance, antitrust is principally concerned with static efficiency—the
allocation of goods and services over the short run. Dynamic efficiency, which refers to
the ability of a market or an economy to produce innovation, is also important to
antitrust. Meanwhile, patent law spurs invention and innovation6 by providing creators of
6
While invention and innovation may be often used interchangeably in common parlance, economists
draw a clear distinction between the two terms. Invention refers to the creation of a new technology or
product, or a substantial improvement of an existing one. Innovation refers to the development and
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patentable inventions a period of exclusivity, during which the patentee has the right to
exclude anyone from practicing and commercializing the invention.7 This exclusivity is
intended to allow the patentee to impose a supra-competitive price for its innovation so
that it can recoup its R&D investment. Users of the innovation and the end consumers
commercialization of a new technology into a good or service that will redound value to consumers. See
Stuart Macdonald, Exploring the Hidden Costs of Patents, in GLOBAL INTELLECTUAL PROPERTY RIGHTS:
KNOWLEDGE, ACCESS AND DEVELOPMENT 13, 23 (Peter Drahos & Ruth Mayne eds., 2002) (“An invention
is a discovery: an innovation is a product or service that is new to the market, or simply new to the
adopter.”); Keith E. Maskus, Sean M. Dougherty & Andrew Mertha, Intellectual Property Rights and
Economic Development in China, in INTELLECTUAL PROPERTY AND DEVELOPMENT: LESSONS FROM
RECENT ECONOMIC RESEARCH 295, 299 (Carsten Fink & Keith M. Maskus eds., 2005) (“Invention refers to
the creation of new knowledge, and innovation (or commercialization) refers to the development of
marketable products from that knowledge.”). The differentiation of invention and innovation is said to date
back to Joseph Schumpeter. RICHARD R. NELSON & SIDNEY G. WINTER, AN EVOLUTIONARY THEORY OF
ECONOMIC CHANGE 263 (1985). The two do not necessarily go hand in hand. As Schumpeter pointed out
decades ago, it is possible to have innovations without a new invention, whereas invention need not be
followed by innovation. JOSEPH A. SCHUMPETER, BUSINESS CYCLES : A THEORETICAL, HISTORICAL, AND
STATISTICAL ANALYSIS OF THE CAPITALIST PROCESS 84-85 (1939).
One of the controversies regarding patent protection on the one hand, and invention and innovation on
the other hand, is whether the patent system should aim to provide incentives only to invent, or also to
innovate and commercialize inventions. Some believe that the patent system should only be concerned
with inventions, while others insist that patents must provide incentives for both inventions and innovation.
SUBCOMM. ON PATENTS, TRADEMARKS & COPYRIGHTS OF THE SENATE COMM. ON THE JUDICIARY, 85TH
CONG. 2D SESS. AN ECONOMIC REVIEW OF THE PATENT SYSTEM 9 (Comm. Print 1958) (written by
Professor Fritz Machlup) (“[i]t is invention rather than enterprising innovation which the patent system is
supposed to encourage.”); WILLIAM J. BAUMOL, THE FREE MARKET INNOVATION MACHINE 65-67 (2002)
(using ancient China, ancient Rome and the former Soviet Union to illustrate that innovation is more
important than invention in promoting economic growth); ADAM B. JAFFE & JOSH LERNER, INNOVATION
AND ITS DISCONTENTS: HOW OUR BROKEN PATENT SYSTEM IS ENDANGERING INNOVATION AND PROGRESS,
AND WHAT TO DO ABOUT IT 43 (2004) (using Xerox’s photocopying machine to illustrate that patent
protection must aim to provide incentives both to invent and to innovate). Some have even argued that the
patent system should only protect innovation. DIRECT PROTECTION OF INNOVATION 1-34 (William
Kingston ed., 1987) (proposing property right system that comes into effect only when new product is
introduced to market). There has been no definitive resolution of this debate. See F.M. Scherer, The
Economics of the Patent System, in INDUSTRIAL MARKET STRUCTURE AND ECONOMIC PERFORMANCE 439,
441 (F.M. Scherer ed. 1980) (hereinafter “Economics of Patent System”).
This Article will make no attempt to resolve this debate. In keeping with the more contemporary views
of commentators such as Baumol, Jaffe, and Lerner, it will proceed on the premise that patent protection
provides incentives for both invention and innovation. These two terms, and the related terms of
“inventors” and “innovators,” will thus be used interchangeably in this Article as far as their relationship
with patent. Efforts will be made to specify the sense in which the two terms are used where necessary.
7
The right to exclude granted by the patent law to the patentee is sometimes known as patent monopoly.
See Int’l Wood Processors v. Power Dry, Inc., 792 F.2d 416, 426 (4th Cir. 1986) (“Since patent law grants
a patent holder the right to exclude others for a period of seventeen years, the property right thereby created
is often referred to as either a limited or patent monopoly. Even though the patent statute does not describe
a patent “monopoly,” the exclusive rights granted to a patent holder permit exploitation of the patent free
from competition for seventeen years and amount to no less however called.”). While that term may be apt
in a loose sense, in a strict antitrust sense, patents need not confer a monopoly. Whether patent exclusivity
confers monopoly power crucially depends on the existence of alternatives to the patented technology,
barriers of entry to the innovation market, and the availability of substitutes in the final product market. In
fact, a patent does not confer a monopoly in most cases. Therefore, for the sake of accuracy, this Article
will use the term “patent exclusivity” rather than “patent monopoly.”
Posner and Landes similarly criticize this lack of precision in terminology, arguing that the facile
characterization of patent exclusivity as monopoly “led judges to suppose that there is an inherent tension
between intellectual property law, because it confers ‘monopolies,’ and antitrust law, which is dedicated to
overthrowing monopolies. That was a mistake. At one level it is confusion of a property right with a
monopoly.” WILLIAM M. LANDES & RICHARD A. POSNER, THE ECONOMIC STRUCTURE OF INTELLECTUAL
PROPERTY LAW 374 (2003).
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will thus have to pay a higher price for the technology in the short run. An economy’s
ability to generate innovations over time is known as dynamic efficiency. Under patent
law, static efficiency, or short-run consumer welfare, is sacrificed for dynamic efficiency.
Based on this basic view of the goals of patent and antitrust laws, a number of
courts have noted the tension between them, at least over the short term. In SCM Corp. v.
Xerox Corp., the Second Circuit observed that:
The conflict between the antitrust and patent laws arises in the methods they
embrace that were designed to achieve reciprocal goals. While the antitrust laws
proscribe unreasonable restraints of competition, the patent laws reward the
inventor with a temporary monopoly that insulates him from competitive
exploitation of his patented art.8

In International Wood Processors v. Power Dry, Inc., the Fourth Circuit expressed a
similar view that “there may be conflict between the patent laws on the one hand, which
encourage monopoly power by granting patent holders the right to exclude and be free
from competition, and the antitrust laws, on the other hand, which generally proscribe
monopoly and encourage competition.”9 Commentators have similarly remarked on the
conflict between patent and antitrust. In his seminal article on the patent-antitrust
interface, Professor Louis Kaplow characterizes this conflict as “even more deep-seated
than is generally perceived.”10
¶9
The conflict between these two bodies of law has also been described as overstated.
It has been argued that they in fact share similar goals. Like patent law, antitrust is
concerned with dynamic efficiency. This concern is motivated by the fact that in the long
run, the greatest enhancement to consumer welfare comes not from lower prices obtained
from static competition, but from the emergence of new technology and new products.
There is a wealth of economic evidence that shows that innovation has been the single
most significant source of economic growth and improvement in general welfare.11
Meanwhile, patent law also considers consumer welfare and is cognizant of the harm that
patent exclusivity inflicts on consumers. The tradeoff between static welfare loss from
short-run supra-competitive pricing and dynamic efficiency gains from more abundant
innovation over time is said to be implicitly struck by Congress when it set the length and
breadth of patent rights.
¶10
This more conciliatory view of the patent-antitrust conflict has received support
from a number of prominent scholars in antitrust, patent, and innovation economics.
Professor Suzanne Scotchmer, a leading innovation economist, believes that the tension

8

645 F.2d 1195, 1203 (2d. Cir. 1981).
Int’l Wood Processors, 792 F.2d at 426.
10
Louis Kaplow, The Patent-Antitrust Intersection: A Reappraisal, 97 HARV. L. REV. 1813, 1815-16
(1984); see also Aaron Xavier Fellmeth, Copyright Misuse and the Limits of the Intellectual Property
Monopoly, 6 J. INTELL. PROP. L. 1, 3 (1998) (recognizing conflict between two bodies of law); David
McGowan, Networks and Intention in Antitrust and Intellectual Property, 24 J. CORP. L. 485, 485, n. 1
(1999) (same).
11
Robert M. Solow, A Contribution to the Theory of Economic Growth, 70 Q. J. ECON. 65 (1956);
Robert M. Solow, Technical Change and the Aggregate Production Function, 39 REV. ECON. STATS. 312
(1957); Paul M. Romer, Increasing Returns and Long-Run Growth, 94 J. POL. ECON. 1002 (1986);
ELHANAN HELPMAN, THE MYSTERY OF ECONOMIC GROWTH 34-54 (2004).
9
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between patent and antitrust only exists in the short run.12 Professor Mark Lemley, a
leading patent scholar, characterizes the view that antitrust focuses on static efficiency
while patent law pursues dynamic efficiency as “oversimplified.”13 Professor Herbert
Hovenkamp, the author of the leading antitrust treatise, calls the patent-antitrust conflict
“readily exaggerated.”14 He notes that in most cases in which there is an appearance of a
conflict, a deeper understanding of patent and antitrust policies will help one realize that
none exists.15 In the few cases that do present a genuine conflict, “a significant portion of
it is explained by deep uncertainty about the optimal amount and scope of IP protection.
As long as that uncertainty remains, there will always be tension between IP and
antitrust.”16 This is a key insight into the patent-antitrust interface. The conflict between
these two areas of law is the most acute when antitrust policy may undermine innovation
incentives by limiting a patentee’s ability to exploit its patent.
¶11
Between these two areas of law, antitrust is probably the one with better-defined
goals and policies.17 There is a clear consensus that antitrust protects consumer welfare.
The major theoretical debates in the field focus on how this is achieved in different
contexts, such as resale price maintenance and unilateral conduct by a monopolist, which
remains highly controversial. While the calibration and implementation of antitrust
policy in these contexts may seem open-ended, the goals are fairly well defined: the
maximization of consumer welfare through competition, both in terms of product and
innovation.18 Antitrust encourages firms to compete in both the final product market and
the technology market. As far as the patent-antitrust interface is concerned, the two
paramount considerations for antitrust are the consumer harm resulting from restrictive
patent exploitation practices and foreclosure of innovation opportunities by a dominant
patentee against rival technology developers.
¶12
Patent law does not share the same clarity in policy.19 The primary goal of patent
law of course is to encourage innovation. Patent law, however, does not pursue
innovation at all costs. Otherwise, it would have stipulated exclusivity of unlimited
duration and a much more expansive scope of rights. As some commentators have
recognized, there can be too much innovation. Innovation is excessive when the social
costs of an innovation outweigh its social benefits. Society as a whole would be better
off if the resources devoted to develop that innovation are channeled to alternative uses
instead. Professors Michele Boldrin and David Levine formulate the test slightly
12

SUZANNE SCOTCHMER, INNOVATION AND INCENTIVES 161 (2004) (“This is more a short-run tension
than a long run tension, since in the long run intellectual property law leads to innovation, which improves
the welfare of consumers. Since consumer welfare is the concern of competition law, there is no
fundamental inconsistency.”).
13
Mark A. Lemley, Industry-Specific Antitrust Policy for Innovation 2 (2010), available at
http://ssrn.com/abstract=1670197 [hereinafter Industry-Specific Policy].
14
Herbert J. Hovenkamp, Restraints on Innovation, 29 Cardozo L. Rev. 247, 247 (2007) [hereinafter
Restraints on Innovation].
15
Id. at 247-48.
16
Herbert J. Hovenkamp, United States Antitrust Policy in an Age of IP Expansion, in INTERNATIONAL
ANTITRUST LAW & POLICY: FORDHAM CORPORATE LAW 225, 226 (Barry Hawk ed., 2004) [hereinafter Age
of IP Expansion].
17
Herbert J. Hovenkamp, The Intellectual Property-Antitrust Interface, in 3 ISSUES IN COMPETITION
LAW AND POLICY 1979, 1982 (ABA Section of Antitrust Law, 2008) [hereinafter Intellectual PropertyAntitrust Interface].
18
Id. at 1982; Age of IP Expansion, supra note 16, at 226.
19
Intellectual Property-Antitrust Interface, supra note 17, at 1983.
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differently, asserting that an optimal level of innovation is attained when the value of an
innovation as determined in a competitive market covers its R&D costs.20 Beyond that,
innovation becomes excessive. To take a systemic perspective, patent protection is
optimal when the marginal social benefits of protection equals its marginal social costs.21
It should be obvious that such a condition for optimality requires balancing of
countervailing policy considerations and results in less determinacy in patent policy than
the focus on consumer welfare found in antitrust law.
B. Long-Run Divergences Between Patent and Antitrust
¶13

The conciliatory view that the tension between patent and antitrust is confined to
the short run is overly optimistic; the conflict in fact extends to the long run. While it is
true that both antitrust and patent laws seek to encourage innovation, they seem to share
contrary visions of what kind of market structure is most conducive to it. This harkens to
the Schumpeter-Arrow debate that has been continuing in economics since Joseph
Schumpeter first made the famous claims that a monopolist may have greater incentives
than competitive firms to innovate and that markets progress through creative destruction
whereby firms compete for the market through innovation, displacing an old monopoly
with a new one.22 Kenneth Arrow and others have since challenged these claims,
asserting that innovation is more abundant in a competitive environment.23 According to
Arrow, monopolists tend to avoid drastic innovations that will displace its existing
product in the market. A monopolist’s competitors do not bear the cost of the loss of
profit from its previous dominant product, and a monopolist may not stand to gain much
from innovation. This is known as the replacement effect, which deters innovation by
monopolists. This debate has spawned a large body of literature, both empirical and
theoretical, that seeks to verify Schumpeter and Arrow’s claims.24 It remains largely
unresolved.25
20

MICHELE BOLDRIN & DAVID K. LEVINE, AGAINST INTELLECTUAL MONOPOLY 127 (2008). This,
again, is an important insight. As will be explained subsequently, there is a tendency in the existing
literature to assume that patentee reward should allow the patentee to capture the full value of its
innovation. Allowing the patentee to do so would amount to a windfall. The patent system, in conjunction
with antitrust law, provides sufficient incentives to potential inventors so long as they are allowed to
recover their R&D expenditure, including the opportunity costs of innovation (what the inventor would
have earned in its next best endeavor).
In fact, it has been widely noted in the economics literature that competitive patent races can result in
substantial waste in resources. The R&D effort invested by firms to win the race is excessive. See, e.g.,
Partha Dasgupta & Joseph Stiglitz, Industrial Structure and the Nature of Innovative Activity, 90 ECON. J.
266 (1980); Jennifer F. Reinganum, A Dynamic Game of R and D: Patent Protection and Competitive
Behavior, 50 ECONOMETRICA 671 (1982); Pankaj Tandon, Rivalry and the Excessive Allocation of
Resources to Research 14 BELL J. ECON. 152 (1983); Partha Dasgupta & Paul Stoneman, The Economic
Theory of Technology Policy: An Introduction, in ECONOMIC POLICY AND TECHNOLOGICAL PERFORMANCE
18-21 (Partha Dasgupta & Paul Stoneman eds, 1987).
21
Kaplow, supra note 1, at 1825-26.
22
JOSEPH A. SCHUMPETER, CAPITALISM, SOCIALISM AND DEMOCRACY 87-120 (2010).
23
Kenneth J. Arrow, Economic Welfare and the Allocation of Resources for Invention, in THE RATE
AND D IRECTION OF INVENTIVE ACTIVITY: ECONOMIC AND SOCIAL FACTORS 609, 619-20 (Nat’l Bureau of
Econ. Research ed., 1962).
24
Philippe Aghion et al., Competition and Innovation: An Inverted-U Relationship, 120 Q.J. ECON. 701
(2005) (positing inverted-U relationship between market concentration and innovation performance);
Richard J. Gilbert, Looking for Mr. Schumpeter: Where Are We in the Competition-Innovation Debate?, in
6 INNOVATION POLICY AND THE ECONOMY 159 (Josh Lerner et al. eds., 2006) (same); Richard J. Gilbert &
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While the academic debate still rages, policymakers and enforcers nonetheless must
take an explicit or implicit view of the matter. Given the fundamental belief in antitrust
that competition is inherently beneficial to society and is the engine of economic
progress, it should come as no surprise that antitrust generally subscribes to the Arrowian
view. For example, in the Department of Justice-Federal Trade Commission 1995
Guidelines for the Licensing of Intellectual Property, the two agencies identified as a
potential harm of cross-licensing arrangements and patent pools the possibility of a
reduction in innovation competition.26 According to Scotchmer, this theory of harm is
premised on “the economic hypothesis that competition leads to more R&D than
cooperation.”27 In his advocacy for robust antitrust enforcement to foster innovation,
Professor Jonathan Baker posits that firms innovate in an attempt to escape product
market competition.28 In the eyes of antitrust enforcers and commentators alike,
competition promotes innovation.
¶15
Given the ideological underpinning of patent law and its expansionist tendencies
over the last two decades, one may conclude that patent law emerges on the
Schumpeterian end of the debate. A preoccupation with promoting technological
competition is generally absent in patent doctrines. The increasingly relaxed standard for
patentability and the expanding scope of patent rights mean that it is easier than before
for an innovator to exclude rivals from competition. This enhanced ability to exclude in
turn facilitates the acquisition of market power in the product market. If the central
policy goal of patent law is to encourage innovation, the implicit assumption seems to be
that dominant firms produce more innovation. Moreover, patent law has not been
particularly accommodating to follow-on innovation, which may often compete with the
original one. The Federal Circuit has interpreted the doctrine of reverse equivalents very
narrowly, which allows a literally infringing invention to escape infringement if it
represents a substantial improvement of the patented technology. 29 A more liberal
application of this equitable doctrine would allow follow-on innovators to pursue
substantial improvements without fear of infringement or strategic behavior by the initial
innovator. Not only is the reverse equivalents doctrine rarely invoked, but there are even
doubts as to its continual validity.30 It thus seems that patent law does not actively
encourage innovation through competition, evincing a Schumpeterian view of innovation.
Steven C. Sunshine, The Use of Innovation Markets: A Reply to Hay, Rapp and Hoerner, 64 ANTITRUST
L.J. 75 (1995) (summarizing relevant literature).
25
SCOTCHMER, supra note 12, at 173 (noting that whether competition delivers more innovation than
concentrated markets depends on a range of factors); F.M. Scherer, Antitrust, Efficiency, and Progress, 62
N.Y.U. L. REV. 998, 1011 (1987) [hereinafter Antitrust, Efficiency, and Progress] (“When the general
advance of knowledge opens up opportunities for technological improvements at a fast pace, innovation is
likely to proceed most rapidly under relatively fragmented (but not atomistic) market structural conditions.
When the relevant knowledge base advances slowly, monopolies or tightly-knit oligopolies are likely to
innovate more rapidly than fragmented industries.”). Cf. Industry-Specific Policy, supra note 13, at 2 (“In
fact, however, there is substantial evidence suggesting competition itself may act as a greater spur to
innovation than monopoly.”).
26
U.S. Department of Justice and Federal Trade Commission Antitrust Guidelines for the Licensing of
Intellectual Property (1995) 28-29, reprinted in 4 Trade Reg. Rep. (CCH) ¶ 13,132.
27
SCOTCHMER, supra note 12, at 172.
28
Jonathan B. Baker, Beyond Schumpeter vs. Arrow: How Antitrust Fosters Innovation 7 (June 2007),
available at http://ssrn.com/abstract=962261.
29
Dan L. Burk & Mark A. Lemley, Policy Levers in Patent Law, 89 VA. L. REV. 1575, 1657 (2003).
30
Tate Access Floors v. Boyden Power Brake Co., 279 F.3d 1357, 1368 (Fed. Cir. 2002) (suggesting
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C. Theoretical Approaches to the Patent-Antitrust Interface
1. Michael Carrier’s Innovation-Based Framework
¶16

Given the theoretical complexity of the patent-antitrust interface, it is no surprise
that it has been the subject of much scholarly writing over the years. Commentators have
suggested a variety of approaches to the patent-antitrust interface. Professor Michael
Carrier argues that dynamic efficiency considerations should trump consumer welfare
concerns in patent-antitrust cases.31 He proposed a framework for resolving patentantitrust cases in which a presumption of legality applies to a patent exploitation practice
if the patentee can provide a plausible business justification that is only rebutted if a
plaintiff can show that innovation is easy to create or difficult to imitate, contending that
there are market-based incentives for innovation, and that innovation in the industry tends
to be cumulative.32 The defendant is then allowed to establish the sur-rebuttal by
furnishing evidence of innovation in the industry.33 There is no meaningful balancing of
the conflicting static and dynamic efficiency considerations underlying the patentantitrust interface, which he believes to be beyond judicial capability.34
¶17
Carrier does not seem to limit the sur-rebuttal to patentable innovations; he only
requires evidence of innovation.35 Given this broad understanding of innovation, it
would take an unusually stagnant industry to deny the defendant evidence to establish the
sur-rebuttal. The consequence is that patent exploitation practices will be almost always
upheld.36
¶18
An anomaly in Carrier’s innovation-based framework is that it attempts to resolve
two areas of law that individually balance static and dynamic efficiencies without
resorting to balancing.
While Carrier’s framework would certainly improve
administrability—it effectively simplifies the entire patent-antitrust enterprise into one
inquiry: the existence of innovation of any kind in an industry—it overlooks the reality
that restrictive patent exploitation practices can and do harm consumers.
Administrability is achieved by ignoring one side of the balance altogether.
Unfortunately, the existence of innovation in an industry does not render irrelevant the
potential consumer harm of these practices. Concerns about judicial competence do not
warrant jettisoning the fundamental considerations of antitrust from the analysis
altogether. Therefore, while one must be mindful of the limits of judicial competence in

that doctrine had no further relevance after passage of the 1952 Patent Act).
31
Carrier, supra note 1, at 816-33.
32
Id. at 817-19.
33
Carrier seems to have implicitly accepted the view that consumer welfare has been adequately taken
into account within patent law.
34
Id. at 799-800.
35
In fact, one may argue that given today’s relaxed standard for patentability, even an insistence of
patentable innovations would not have been much of a hurdle. JAFFE & LERNER, supra note 6, at 142-43
(“While there is a formal process of patent examination, in practice the system seems more akin to a
registration system: in many cases it appears that a determined patentee can get almost any award he
seeks.”).
36
If one examines closely the way Carrier’s framework is constructed, the rebuttal, the most complex
step in it, is largely superfluous. When confronted by a challenge to a patent exploitation practice, an
antitrust court need only ask itself whether there is evidence of innovation in the industry. If so, the case is
closed and the practice is upheld.
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antitrust cases, it is equally important not to underestimate it and over-simplify the
analysis in the name of administrability.
2. Louis Kaplow’s Ratio Test
¶19

Of all the approaches that have been proposed for the patent-antitrust interface,
Professor Louis Kaplow’s framework remains the most sophisticated and nuanced. 37 The
pivot of Kaplow’s framework is the ratio test, which is defined as patentee reward
divided by monopoly loss. Patentee reward and monopoly loss refer to the incremental
reward and loss caused by a patent exploitation practice. 38 There is a ratio associated
with every type of patent exploitation practice.39 In order to determine whether antitrust
law should permit a particular patent exploitation practice, the ratio associated with that
practice is compared with a benchmark ratio of some kind. The benchmark suggested by
Kaplow is the patentee reward-monopoly loss ratio implicit in the optimal patent life.40
This ratio represents the most cost-effective way society can induce invention by
adjusting patent life. If a ratio associated with a particular patent exploitation practice is
lower than the optimal ratio, the practice should be prohibited. If it is higher than the
optimal ratio, the practice should be allowed, subject to the requirement that patent life
should be shortened accordingly.
¶20
Despite the theoretical elegance of his framework, Kaplow himself acknowledges
that there are considerable obstacles to applying it in real-world contexts. As a secondbest solution, Kaplow proposes a cost-effectiveness analysis, which requires the antitrust
agency to derive the ratio for all possible patent exploitation practices and align them
from the highest to the lowest. A comparison can then be made of the practices that are
currently allowed and prohibited to ensure that the total reward is obtained from practices
that have the highest ratios.41 However, he believes that even this second-best
formulation is probably too difficult to apply. In its place Kaplow suggests a number of
factors which would facilitate the application of the test, including “the extent to which
the reward is pure transfer, the portion of the reward that accrues to the patentee, and the
degree to which the reward serves as an incentive.”42 When applying his framework to
37

Kaplow, supra note 1.
The reason that patentee reward as opposed to marginal social benefit is used is because the optimum
patent life is set as given, which is determined by the marginal social benefit and marginal social cost of granting
patent protection. Once the optimum patent life has been set, what the ratio test seeks to answer is “whether the
total reward to the patentee implicit in the optimal patent life can be achieved at a lower cost.” Kaplow, supra
note 1, at 1831.
39
Strictly speaking, there is a ratio associated with every patent exploitation practice for every patent,
because patentee reward depends on “a number of factors, including the market value of the invention, the
structure of the market involving the patented process or product, and the attributes of the patentee (such as
marketing and production capacities) that determine its range of options within the market.” Id. at 1823.
However, for ease of application, it is assumed that there is a generalized ratio for every type of patent
exploitation practice.
40
When determining the optimal patent life by comparing the marginal social benefit and marginal social cost
of granting patent protection, the policymaker will implicitly determine an optimal patentee reward-monopoly
loss ratio. This is because marginal social benefit is dependent on incremental patentee reward, and monopoly
loss is one very important component of the marginal social cost.
41
This analysis is called the cost-effectiveness analysis because the goal of the exercise is to obtain the same
total reward in the most cost-effective manner, i.e., by incurring the least aggregate monopoly loss.
42
Id. at 1842. The first of these factors requires some explanation. By a pure transfer, Kaplow refers to a
situation in which a patent exploitation practice results in transfer of surplus from one group in society to
38
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concrete examples of patent exploitation practices, Kaplow focuses on the effects of a
practice on the ratio’s denominator and numerator. Therefore, if a practice were likely to
result in a substantial increase in patentee reward without a proportionate increase in
monopoly loss, Kaplow would permit it. An example would be a practice that effectuates
a pure transfer. If a practice has the opposite effects on the denominator and the
numerator, Kaplow would prohibit it. An example would be a price fixing cartel
disguised as a licensing arrangement with price restrictions.
¶21
There are two important omissions, however, in Kaplow’s framework. First, there
is insufficient consideration of the extent to which patentee reward provides incentives to
innovate.43 Kaplow posits a three-step causal link between patentee reward and social
benefits. The first is that an increase in patent term or an expansion of the scope of
permissible patent exploitation increases patentee reward, which in turn incentivizes
innovation, which in turns redounds benefits to society. His ratio test takes as a given
that all three steps in the link are valid, which allows him to focus on the relationship
between antitrust restrictions on patent exploitation and patentee reward. While he does
briefly discuss how innovators may perceive patentee reward from different types of
restrictive practices differently, he fails to consider the more crucial question of the
incentive effect of patentee reward.44
¶22
Kaplow acknowledges that “our knowledge of the functional relationships between
the separate links in the chain connecting patent life to social benefits remains quite
limited.”45 That was true in 1984. Our understanding of the relationship between
patentee reward and innovation incentives has substantially improved since then. There
is now a wealth of theoretical and empirical economic literature that questions the second
step in Kaplow’s causal chain. Once the causal chain breaks down, one can no longer
focus on patentee reward, and must begin to consider difficult questions about whether
the static efficiency loss caused by a patent exploitation practice serves any useful social
purpose, or is merely a windfall to patentees. In other words, instead of focusing on
patentee reward, the inquiry must directly address innovation incentives and the social
benefits of patent protection. A focus on innovation incentives requires us to distinguish
between different types of innovation.
¶23
As it turns out, the degree of dependency on patent protection for innovation
incentives varies across types of innovation. For example, economists have found that,
perhaps due to the greater difficulty for rivals to reverse engineer contemporary
technology, process innovation tends to be less reliant than product innovation on patents
for protection.46 In fact, patentee reward was found to be the least important means by
which an innovator reaps benefits from process innovation. The diversity of innovation

another, such as licensees to the patentee, without an attendant increase in deadweight loss. In the case of a pure
transfer, the patentee reward may increase substantially without a corresponding increase in monopoly loss.
Therefore, all else being equal, a patent exploitation practice that results in a pure transfer is to be preferred to
one that does not.
43

While he includes the relationship between patentee reward and innovation incentives as one of the
factors in his third-best formulation of the ratio test, he does not provide very detailed guidance on how this
factor should be applied in the analysis. This Article seeks to remedy that.
44
Id. at 1838.
45
Id. at 1824.
46
Richard C. Levin et al., Appropriating the Returns from Industrial Research and Development, in
1987:3 BROOKINGS PAPERS ON ECONOMIC ACTIVITY 783, 794–95 (1987).
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will be explored in greater detail in Section Error! Reference source not found..
Suffice it for now to note that Kaplow overlooked this very important issue.
¶24
Second, Kaplow’s framework pays scant attention to the importance of cumulative
innovation, and how patent exploitation practices may hamper such innovation. Given
the dual focus of his framework on patentee reward and monopoly loss, cumulative
innovation cannot be easily incorporated. Again, since his article, economists have
substantially improved our understanding of innovation generally and cumulative
innovation in particular. Cumulative innovation has been shown to be of great
importance to technological progress, and patent exploitation practices may significantly
affect the prospects of cumulative innovation. Therefore, cumulative innovation must be
incorporated in the analysis. The loss of potential cumulative innovation represents a
serious social cost of patent rights, and hence belongs to the denominator side of his ratio.
Just as the numerator has been redefined to focus on innovation incentives and social
benefits, the denominator also needs to take into account loss of cumulative innovation.
¶25
One further weakness in Kaplow’s framework is its universalist approach to the
optimization of the scope of patent protection and patent-antitrust rules. He attempts to
obtain one optimal patent life and one patentee reward-monopoly ratio for each and every
patent exploitation practice, regardless of the market environment in which it is pursued.
He fails to consider the possibility that the optimization exercise may yield different
results according to the industry, or even the type of innovation, at issue.47 Economic
literature suggests that the importance of patent protection as a source of innovation
incentives differs widely by industry and type of innovation. A one-size-fits-all approach
to the optimization exercise is hence inappropriate. It would perpetuate the crudeness of
the tradeoff between static and dynamic efficiencies inhered in the patent system, which
will be discussed below. While patent law, at least the statutory part of it, may be bound
to such a universalist approach (unless Congress decided to take an industry-specific
approach to patent protection), there is no reason that antitrust should not take advantage
of the case-specific nature of its decision-making process to take full account of the
characteristics of the industry and the innovation at issue. This is what the approach to
the patent-antitrust interface proposed in the next Section endeavors to do.
D. Judicial Deference to Dynamic Efficiency Considerations
¶26

Before launching a theoretical examination of the patent-antitrust interface, it is
important to examine the prevailing judicial attitude toward it. The patent-antitrust
interface requires a balancing between static and dynamic efficiencies. Dynamic
efficiency considerations are by nature long term. Innovation can take years to
accomplish, especially for research- and resource-intensive R&D activities such as those
found in the pharmaceutical industry.48 To complicate matters further, innovation can be
highly uncertain. R&D efforts obviously can succeed or fail. An assessment of dynamic
efficiency considerations may require the antitrust courts to enter the perilous territory of

47

This oversight again is excusable because awareness of the industry-specific variations in dependence
on innovation incentives only came about since the publication of Kaplow’s article. Kaplow’s framework
indeed reflects the state-of-the-art of our knowledge about the patent system in 1984.
48
Burk & Lemley, supra note 29, at 1581 (noting that the entire development process for a new drug
can take a decade).
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estimating the likelihood of success for R&D projects. These myriad complications
mean that the antitrust courts are generally loathe to second-guess dynamic efficiency
arguments. It sometimes seems that if a dynamic efficiency argument passes the muster
of minimum credibility, the courts defer to it.49 It is aptly illustrated by the D.C. Circuit’s
treatment of Microsoft’s arguments regarding its development of a Java Virtual Machine
that is incompatible with its rival Sun Microsystem’s version. The court was unwilling to
scrutinize the veracity of Microsoft’s innovation even though there was ample evidence
that Microsoft had developed its own Java Virtual Machine with the express goal to
create confusion in the market and to undermine Sun’s product. 50 Similarly, in predatory
product design cases, the courts have been reluctant to challenge innovation-based
defenses to predatory product design claims unless there is clear evidence of predatory
intent on the part of the defendant to use a technological feature to exclude rivals.51 This
deferential judicial attitude toward innovation is also evident in other important patentantitrust cases.52
¶27
While a prudent approach to dynamic efficiency arguments is commendable, this
author believes that the antitrust courts have shown too much deference to them. The
tradeoff in patent law between static and dynamic efficiencies was made when Congress
set the patent term and the scope of patent rights. The one-size-fits-all approach under
the patent statute means that the balance struck is necessarily a crude one.53 This balance
thus should not be assumed to be universally optimal. Furthermore, while it is true that
longer-term and more general policy judgments are usually left to the legislature and that
innovation-based arguments are by nature long-term, it is not true that only Congress is
equipped to make policy judgments concerning innovation. Even in patent law, the
courts are actively involved in fashioning micro policy decisions through individual
cases. Professors Dan Burk and Mark Lemley have argued that patent law provides the
courts with a range of micro and macro policy levers to make sector-specific adjustments
to the various parameters of patentability and patent rights.54 These decisions may have
long-term and broad implications for innovation policy. The Federal Circuit’s decision to
permit patents for business methods is a case on point.55
49

In fact, according to Professor Michael Carrier, this is exactly what the courts should do. Carrier,
supra note 1, at 762–64.
50
United States v. Microsoft Corp., 253 F.3d 34, 55 (D.C. Cir. 2001). Admittedly, there was evidence
that Microsoft’s Java Virtual Machine was superior to Sun’s in some ways. This case thus presented a
particularly difficult set of facts to the court.
51
See, e.g., C.R. Bard, Inc. v. M3 Sys., Inc., 157 F.3d 1340 (Fed. Cir. 1998).
52
See United States v. General Elec. Co., 272 U.S. 476 (1926); Standard Oil Co. v. United States, 283
U.S. 163 (1931); Rambus, Inc. v. FTC, 522 F.3d 456 (D.C. Cir. 2008); Schering-Plough Corp. v. FTC, 402
F.3d 1056 (11th Cir. 2005); Matsushita Elec. Indus. Co. v. Cinram, 299 F.Supp.2d 370 (D. Del. 2004); In
re Indep. Serv. Orgs. Antitrust Litig. (Xerox), 203 F.3d 1322 (Fed. Cir. 2000); Filmtec Corp. v.
Hydranautics, 67 F.3d 931 (Fed. Cir. 1995); Brunswick Corp. v. Riegel Textile Corp., 752 F.2d 261 (7th
Cir. 1984); Foremost Pro Color, Inc. v. Eastman Kodak Co., 703 F.2d 534 (9th Cir. 1983); Berkey Photo,
Inc. v. Eastman Kodak Co., 603 F.2d 263 (2d Cir. 1979).
53
There are of course sector-specific statutes such as the Semiconductor Integrated-Circuit LayoutDesign Act 2000 and the Hatch-Waxman Act that make adjustments to this uniform approach.
54
See Burk & Lemley, supra note 29, at 1638–67. They note, however, that while judicial application
of patent law is at times industry-specific, “there is no reason to believe that these [sector-specific]
differences in the law represent a reasoned response to industry differences.” Id. at 1577. In fact, they
assert that with respect to biotechnology and software, the Federal Circuit “has gotten the policy precisely
backwards.” Id. at 1578.
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Policy decisions of general application, such as the length of patent term (and
arguably a dramatic extension of patentable subject matter such as that undertaken in
State Street Bank), no doubt should be reserved for Congress. In contrast, micro policy
decisions about the optimal scope of patent rights in a particular case, which antitrust
courts make when determining the legality of patent exploitation practices, are rightfully
the province of the judiciary. These decisions present no greater obstacles to the antitrust
courts than do merger review cases. There is no reason to believe that forecasting how a
market will be affected by a merger transaction and how competitors will interact with
each other afterward is any more difficult than predicting how a patent exploitation
practice will impact innovation. If the antitrust courts can handle merger review cases,
applying meaningful scrutiny to innovation-based arguments should not elude them. The
long-term nature of dynamic efficiency considerations is a reason for caution, not
abdication of responsibility, by the antitrust courts.
II. A THEORETICAL APPROACH TO THE PATENT-ANTITRUST INTERFACE
A. An Overview

As suggested by Hovenkamp,56 much of the confusion regarding the patentantitrust interface stems from the lack of consensus about the optimal amount of patent
protection. Antitrust restrictions on patent exploitation affect the scope and the exercise
of patent rights, which in turn alters the size of patentee reward. As such, the patentantitrust rules are an integral part in the determination of the optimal patent protection
(i.e., how many incentives to offer to induce innovation). At the same time, it is
impossible to delineate the optimal scope of the patent-antitrust rules without placing
these rules in the context of the overall determination of optimal patent protection. The
patent-antitrust rules are but one of the many pieces of the puzzle.
¶30
There are four relevant parameters in the determination of optimal patent
protection: (1) social benefits; (2) social costs; (3) private benefits; and, (4) private costs
of patent protection.57 Social benefits can be broken down to external benefits and
private benefits. Likewise, social costs can be broken down to external costs and private
costs. Private costs and benefits are those that directly affect the innovator in question.
To simplify, they are the rewards received by the innovator from its innovation and the
R&D costs incurred by the innovator to develop the technology. External benefits and
costs are those that affect other firms in the industry and society as a result of the
innovation.
¶31
The external benefits of patent protection include the direct benefits of the
innovation for society. For example, if an innovation is a cost-reducing technology, its
direct social benefit is the cost savings achieved by society from the adoption of the
¶29

56

Age of IP Expansion, supra note 16, at 226.
Here it is assumed that the social costs and benefits of patent protection encompass those of the
underlying innovation that is being patented. The tacit assumption is that the innovation at issue would not
have been created absent patent protection. Strictly speaking, the social benefits and costs of patent
protection are only the value and costs of innovation that would not have been created without patent
protection. Some, and perhaps a great amount of, innovation may still be created in the absence of a patent
system. This distinction would be important for more systemic issues such as whether a patent system
should be instituted. On the level of individual innovations, for the purpose of our inquiry, it is appropriate
to assume that the social costs and benefits of patent protection and innovation are the same.
57
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technology.58 If an innovation is the development of a new product, the direct social
benefit is the additional amount that consumers are willing to pay for this product, or the
difference in consumers’ willingness to pay for the improved as compared to the original
products.59 As the term “direct social benefits” suggests, social benefits can also be
indirect. These encompass the beneficial impact of an innovation on the R&D programs
conducted by other firms in the industry and on the economy in general,60 and the
possibility of follow-on innovation built on this present innovation. Indirect social
benefits or spillovers of innovation can be substantial.61 Professor William Baumol
estimates that innovators are able to capture only 20% of the value created by their
innovations; the remaining 80% of the value benefits the rest of society.62 He argues that
without these spillovers, a majority of the industrialized world would be condemned to a
pre-Industrial Revolution standard of living.63 Other studies have similarly ascertained
the magnitude by which social benefits of an innovation exceed its private benefits.64
What is particularly noteworthy about these indirect social benefits is the impact of
cumulative innovation on overall social welfare. Many commentators have noted the
importance of cumulative innovation to technological development.65 Therefore, to the
extent that patent-antitrust rules affect the pursuit of cumulative innovation by other
firms, these effects must be taken into account.
¶32
There are two main types of social costs of patent protection. The first is one with
which antitrust commentators are most familiar, the deadweight loss created by the supracompetitive pricing imposed by the patentee. From a social perspective, this cost should
be minimized to the extent possible without substantially undermining innovation
58

Suzanne Scotchmer, Standing on the Shoulders of Giants: Research and the Patent Law, 5 J. ECON.
PERSP. 29, 31 (1991).
59
Id.
60
The beneficial impact of the new knowledge need not be confined to the industry itself, and may
enhance the R&D efforts of firms in other industries. This is especially like with general-purpose
technology, such as computers and the internet, whose beneficial impact on innovation clearly extends
beyond the boundaries of their own respective industries.
61
Baumol refers to the indirect external benefits of innovation as spillovers. BAUMOL, supra note 6, at
124.
62
Id. at 121, 134–35. But see BOLDRIN & LEVINE, supra note 20, at 163–66 (disputing claims that
spillovers of innovation are substantial).
63
Id. at 125.
64
See Jeffrey I. Berstein, The Structure of Canadian Industry R&D Spillovers, and the Rates of Return
to R&D, 37 J. INDUS. ECON. 315, 315-28 (1989) (social value of innovation at least twice as high as private
value for industries studied); Timothy F. Bresnahan, Measuring the Spillovers from Technical Advance:
Mainframe Computers in Financial Services, 76 AM. ECON. REV. 742, 753 (1986) (social benefits from
mainframe computers very substantial); Michael Kremer, Patent Buyouts: A Mechanism for Encouraging
Innovation, 113 Q. J. ECON. 1137, 1141 (1998); Edwin Mansfield et al., Social and Private Rates of Return
from Industrial Innovations, 91 Q. J. ECON. 221, 234 (1977).
65
See Robert P. Merges & Richard R. Nelson, On the Complex Economics of Patent Scope, 90 COLUM.
L. REV. 839, 843–44, 870 (1990) (arguing that patent scope decisions should allow competitive
environment for follow-on innovation); John H. Barton, Patents and Antitrust: A Rethinking of Patent
Breadth and Sequential Innovation, 65 ANTITRUST L. J. 449, 453 (1997) (arguing that follow-on innovators
deserve more protection); Joel Mokyr, The Industrial Revolution and the New Economic History, in THE
ECONOMICS OF INDUSTRIAL REVOLUTION 1 (Joel Mokyr ed., 1989) (“The cumulative effect of small
improvements made by mostly anonymous workers and technicians was often more important than most of
the great inventions.”); Mark A. Lemley, The Economics of Improvement in Intellectual Property Law, 75
Tex. L. Rev. 989, 997 (1997) [hereinafter Economics of Improvement”] (“And since ‘improvements’ may
in many cases dwarf the original work in terms of their practical significance, dynamic market efficiency
over different generations demands such access as well.”).
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incentives. Another social cost is less well-documented and perhaps less understood.
This refers to the cost imposed by a new innovation on the producers of an existing
product, and is sometimes known as the costs of creative destruction. To the extent that
the new innovation renders existing products in the market obsolete, the machineries that
these firms have installed, and the plants that these firms have constructed, to produce
their now-obsolete products may become redundant.66 Digital photography, which has
practically rendered traditional film photography redundant, at least for the leisure
photographers, serves as a fitting example. The machines and plants built to produce
films and film cameras have largely lost their productive value. Firms certainly do not
take into account these welfare losses suffered by their rivals when deciding whether to
pursue an innovation. If anything, they may prefer to inflict these losses on rival firms.
However, from a social perspective, these losses could be so high as to outweigh the
benefits brought forth by the innovation.67 It is possible for society to be better off
without it.
¶33
Finally, another important social cost is the various administrative costs of the
patent system. These include the operating costs of the Patent and Trademark Office and
the courts, the fees and expenses incurred by patent applicants, and the legal costs
incurred by parties in patent litigation. These costs are no doubt substantial.68 They are,
however, mostly relevant on a systemic level. They should have little relevance when
determining optimal patent protection in individual cases.
¶34
Private benefits of innovation and private benefits of patent protection must be
clearly distinguished. This distinction will have considerable relevance to the resolution
of the patent-antitrust conflict. Private benefits of patent protection are estimated against
the counterfactual of what would the reward to the patentee be absent patent protection,69
or in other words, private benefits are the additional value patent protection creates for
the innovator. Private benefits of innovation consist of all the revenue earned by the
innovator from the exploitation of its innovation, including sale of the final product
incorporating the patented technology, licensing of the technology, or even the sale of it
in the form of an assignment.70
¶35
While licensing and assignment of technology depends on patent
protection, product sale does not necessarily rely on it. As it turns out, firms have a
variety of ways to capture the benefits of their innovation. These are known as
“appropriation mechanisms.”71 First, firms can patent their innovation, which would
allow them to exclude competitors from practicing or commercializing the technology.
To the extent that the product incorporating the technology does not face close
substitutes, the patentee will be able to raise the price of the product and profit from the
innovation. The innovator can also resort to trade secrecy and conceal the technology
from its competitors altogether. For example, if a firm is able to keep a cost-cutting
technology secret and utilize it in its production process, it will acquire a cost advantage
66

BAUMOL, supra note 6, at 136–37.
JAMES BESSEN & MICHAEL J. MEURER, PATENT FAILURE: HOW JUDGES, BUREAUCRATS, AND
LAWYERS PUT INNOVATORS AT RISK 98 (2008).
68
ERICH KAUFER, THE ECONOMICS OF THE PATENT SYSTEM 42–43 (1989).
69
SCOTCHMER, supra note 12, at 275.
70
BESSEN & MEURER, supra note 67, at 97.
71
ALEXANDRA ZABY, THE DECISION TO PATENT 30 (2010).
67
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over its rivals and be able to undercut their prices. This will allow the firm to capture
market share from its competitors, especially if the product is homogenous or if the
competing firms’ offerings are close substitutes. Trade secrecy is hence another way for
the firm to profit from its innovation.
¶36
A firm may appropriate returns from its innovation even in the absence of patent
protection and trade secrecy. This related set of appropriation mechanisms generally falls
under the rubric of first-mover advantages. The first firm to come up with a new
technology and commercialize it gains an advantage over its rivals. First, even if the
technology is not protected by trade secrecy (assuming it is a product innovation that is
apparent from the appearance of the product itself, such as a hammer) or patent
protection, it will still take rivals time and money to reverse-engineer the technology.
The technology may be very difficult to reverse-engineer, perhaps because replication of
the technology requires substantial tacit know-how that is not discernible from the
product itself. Even if the technology is not technically very difficult to reverse engineer,
it may take rivals considerable time to do so, simply due to the laborious nature of the
process. The amount of time that rivals need to enter the market through imitation is
called an “imitation lag.”72 The longer is this lag, the greater is the innovator’s firstmover advantage. The innovator will have more time to profit from supra-competitive
pricing before rivals enter the market.
¶37
Through a number of empirical studies, Professor Edwin Mansfield has confirmed
the time-consuming and resource-intensive nature of imitation.73 In a survey published in
1981, Mansfield and his co-authors found that the ratio of imitation costs to innovation
costs was about 0.65, and the ratio of imitation time to innovation time was about 0.70.74
In other words, it takes an imitator 70% of the time and 65% of the cost expended by the
innovator to replicate the technology. In fact, imitation costs were no smaller than
innovation costs in one-seventh of the cases surveyed in their study.75 Imitation is by no
means costless or instantaneous, as is sometimes assumed. If it took an innovator four
years to invent a new technology, the imitator on average would need almost three years
to replicate it. The innovator will have a three-year window to establish its product in the
market and gain consumer acceptance. The innovator will also be able to charge a higher
price in the interim to recoup its R&D costs.
¶38
This first-mover advantage can be enhanced by branding and product
differentiation strategies. These strategies will give the innovator greater customer
loyalty and allow it to more effectively protect its market share after entry by rivals.
More generally, sales and marketing efforts also constitute an appropriation mechanism.76
The most intuitive and direct way to profit from one’s innovation is to engage in sales
and marketing to boost product sales. On the production side, learning curve advantages
have been known to give the innovator an edge over its imitating rivals. By virtue of its
early start, the innovator will be ahead of its rivals on the learning curve, and may

72

Sidney G. Winter, Appropriating the Gains from Innovation, in WHARTON ON MANAGING EMERGING
TECHNOLOGIES 250–51 (George S. Day et al. eds., 2000).
73
See Edwin Mansfield et al, Imitation Costs and Patents: An Empirical Study, 91 ECON. J. 907, 907–17
(1981); Edwin Mansfield, Patents and Innovation: An Empirical Study, 32 MGMT. SCI. 173, 173–80 (1986).
74
Mansfield et. al., supra note 73, at 909.
75
Id. at 910.
76
Levin et al., supra note 46, at 795.
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continue to possess technical and know-how advantages.77 These learning curve
advantages will allow the innovator to produce technically superior products even after
imitation has succeeded.
¶39
The variety of appropriation mechanisms means that private returns to innovation
are likely to substantially exceed private returns to patenting.78 This observation has been
confirmed by a number of empirical studies.79 Using a variety of methodologies, such as
estimating private value of patents from firms’ willingness to pay renewal fees for their
patents, economists have tried to determine the private benefits of patent protection
independent of the value of the underlying technology. Their general conclusions are
that: (1) the private values of patents are highly dispersed; (2) the distribution of values is
highly skewed, with most value accounted for by the top-earning patents; and, (3) the
average value of patents is much lower than the average R&D costs. 80 While the last
conclusion may cause concerns that the patent system generates inadequate innovation
incentives and that innovators are systematically incurring losses from their R&D
activities, the fact that innovation continues to be created in huge number suggests
otherwise.
¶40
In an efficient market, firms could not have been pursuing a loss-making activity
for years without suffering severe consequences. Therefore, the inescapable conclusion
is that firms recover their R&D costs through other means. Patent protection is but one
of the many ways through which R&D investments are recouped. Grilriches, Pakes and
Hall found that the aggregate private value of patents amounts to roughly only 10% to
15% of the total national expenditures of R&D.81 This led Landes and Posner to
conclude that “incremental increases in patent protection are unlikely to influence
inventive activity significantly and incremental reductions might actually enhance
economic welfare.”82 Given that firms rely on a range of appropriation mechanisms to
capture of the value of their innovations,83 the aggregate private benefits of innovation
must be considered when determining optimal patent protection, and by extension, the
optimal patent-antitrust rules.
¶41
Private costs of innovation and patenting again could be different. Strictly
speaking, private costs of innovation refer to the R&D costs incurred to develop an
innovation. Private costs of patenting refer to the costs incurred by a firm to secure a
patent. However, it seems that the two terms are used interchangeably by economists and
77

Id.
BESSEN & MEURER, supra note 67, at 98 (“It follows from such observations as the above that the
value of the patent per se is not the same as the value of the technology to which it is attached. The private
value of the technology is the value of the rents obtained by all means, so this is generally larger than the
value of the relevant patent, often much larger.”).
79
Zvi Griliches, Ariel Pakes & Bronwyn H. Hall, The Value of Patents as Indicators of Inventive
Activity, in ECONOMIC POLICY AND TECHNICAL PERFORMANCE 120 (Partha Dasgupta & Paul Stoneman
eds., 1987); see also Mark Schankerman, How Valuable is Patent Protection? Estimates by Technology
Field, 29 RAND J. ECON. 77 (1998).
80
SCOTCHMER, supra note 12, at 275.
81
Zvi Griliches, Ariel Pakes & Bronwyn H. Hall, The Value of Patents as Indicators of Inventive
Activity, in ECONOMIC POLICY AND TECHNICAL PERFORMANCE 120 (Partha Dasgupta & Paul Stoneman
eds., 1987); see also Schankerman, supra note 79 (patent values only recover 24% of private spending in
R&D); BESSEN & MEURER, supra note 67, at 113 (putting same figure at 3% of private R&D investment).
82
LANDES & POSNER, supra note 7, at 327.
83
For a more detailed discussion of the different appropriation mechanisms for innovators to capture the
value of their innovations see Part Error! Reference source not found..
78
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lawyers alike. When economists speak of and measure patent costs, they seem to have in
mind the R&D costs, perhaps together with the patenting costs.84 For most patents, there
are good reasons to believe that R&D costs dwarf patenting costs.85 The focus of our
attention in the ensuing discussion will be R&D costs.
¶42
How do the patent-antitrust rules fit into the picture? How do the rules relate to all
these parameters? The conventional wisdom is that within the patent system, consumer
welfare loss is traded for patentee reward. In other words, private benefits of innovation
are generated at the expense of external costs. The relationship, however, is more
complex than that. Private benefits, in particular patentee reward, are related to both
external costs and external benefits. Returns from innovation are derived from multiple
sources. In addition to consumer welfare loss, these returns are also derived from the
minimization of spillovers and the denial of follow-on innovation by rival innovators. In
other words, an increase in patentee reward may cause a loss of surplus by other firms
and beneficiaries of spillovers. The tradeoff is hence not just between patentee reward
and consumer welfare loss. It is more accurately characterized as one between patentee
reward and net social benefits.86
B. Determination of Patentee Reward
1. A Costs-Based Approach to Patentee Reward
¶43

From a social perspective, an innovation would be beneficial for society if its social
benefits outweigh its social costs, or if it results in net social benefits. Society would be
better off with the innovation than without it. In addition, society would like to maximize
its net social benefits from each innovation so long as it is made. The decision to pursue
the innovation, however, lies not with society but with the innovator. It is its private
calculus of costs and benefits that determines whether an innovation is made. An
innovator does not care about the net social benefits of its creation. It is only concerned
84
See SCOTCHMER, supra note 12, at 273; see also Schankerman, supra note 79, at 94. Schankerman
found that the top 1% of patents accounted for 12% of the total value of patent rights in the pharmaceutical
industry, 14% in the chemicals industry, 21% for mechanical patents, and 24% for electronics patents. He
further found that the top 5% of patents accounted for 34% of the total value of patent rights in the
pharmaceuticals industry, 38% in the chemicals industry, 50% for mechanical inventions, and 55% for
electronic inventions. Schankerman, supra note 79, at 94.
85
Bronwyn H. Hall, Adam B. Jaffe & Manuel Trajtenberg, Market Value and Patent Citations, 36
RAND J. ECON. 16 (2005) (reporting R&D costs per patent of about $2.8 million in 1996 dollars); Jean O.
Lanjouw & Mark Schankerman, Patent Quality and Research Productivity: Measuring Innovation with
Multiple Indicators, 114 Econ. J. 441 (Apr. 2004) (reporting costs per patent in 1998 dollars to be $4
million for pharmaceutical patents, and around $2 million for chemical, mechanical, and electronics
patents). Meanwhile, the costs of patenting itself are only in the neighborhood of tens of thousands of
dollars. See Gene Quinn, The Cost of Obtaining a Patent in the US, IP WATCHDOG (Jan. 28, 2011, 1:14
PM), http://ipwatchdog.com/2011/01/28/the-cost-of-obtaining-patent/id=14668/ (estimating patent attorney
fees to be $5,000 for an extremely simple technology to more than $15,000 for a highly complex one).
According to the Patent and Trademark Office, the patent filing fee for three claims or less ranges from
$220-330, the patent search fee from $100-$540, and the examination fee from $140-650. See United
States Patent and Trademark Office, Fee Schedule (effective October 2, 2008), available at
http://www.uspto.gov/web/offices/ac/qs/ope/fee2009september15.htm (last visited March 4, 2011).
Adding all these fees together, the costs of obtaining a patent are still dwarfed by the R&D costs.
86
There does not seem to be a tradeoff, at least not a strong one, between other sources of private
benefits and the various components of net social benefits. Increased returns from sales and marketing may
reduce surplus for other firms. However, this has nothing to do with the patent-antitrust interface.
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with its profitability. The alternative to innovation is to spend the funds on another
investment opportunity. A firm contemplating innovation is confronted with an array of
investment options, such as building a new production plant to expand capacity,
launching a marketing campaign to increase sales, improving its in-house IT system to
improve its operational efficiency, or developing a cost-cutting technology that will allow
it to produce its goods more cost-effectively. The firm will choose to pursue innovation
if it promises the highest rate of return, or if returns from innovation cover its direct R&D
costs plus opportunity cost, which would be the returns that the firm can obtain from its
next best investment option. If the returns from innovation slightly exceed its R&D costs
and opportunity cost, the firm will choose to develop the technology.
¶44
The implication is that from the perspective of the optimization of patent protection
and patent-antitrust rules, we would first like to determine the desirability of an
innovation by weighing its social benefits against its social costs. If the former exceeds
the latter, society would benefit from the innovation. Once it is determined that an
innovation creates net social benefits, society would prefer to obtain it at the lowest
possible costs. Society would prefer to offer the innovator a reward just large enough to
cover its private costs of innovation, which now include both direct R&D costs and
opportunity cost. Any reward greater than what is strictly necessary to obtain the
innovation will be socially wasteful and will constitute a windfall to the innovator. The
task of maximizing social gains from an innovation while ensuring that innovation costs
are covered can be achieved through a variety of means, such as adjusting the length of
patent term, the scope of patent rights, or the amount of antitrust restrictions on patent
exploitation. Given that this Article is concerned with the patent-antitrust interface, it
will focus on the last means.87
¶45
In fact, if it was possible for the government to predict accurately ex ante the costs
for developing every innovation that emerges in the economy, it could provide a lumpsum prize to reward innovators.88 So long as the government can make a credible
87

Given the composition of social benefits and social costs, it is obvious that their magnitude is to some
extent dependent on the scope of patent rights and the patent-antitrust rules. When we determine the social
desirability of an innovation, we must do so against a backdrop of patent and antitrust rules. But if our goal
is to determine the optimal scope of patent-antitrust rules, we run the risk of circularity in this exercise. In
economic parlance, there is a risk of endogeneity in the analysis. The problem with determining the social
desirability of an innovation is that it must be done against some background legal rules that in turn affect
its social benefits and costs. For example, legal rules that minimize spillovers and the possibility of
cumulative innovation will foreclose a major source of social benefits. Likewise, legal rules that permit
liberal compulsory licensing may introduce competition and help to drive the price of the product toward
marginal cost. This will help to reduce deadweight loss and hence the social costs. In the ideal world, we
would like to determine the social desirability of an innovation against a set of neutral patent and antitrust
rules. Unfortunately, there are no such rules. Patent and antitrust rules alter the size of patentee reward one
way or the other. The best we can do is first to ascertain the social desirability of an innovation, and then
make adjustments accordingly to maximize its net social benefits. This maneuver is in some ways similar
to Kaplow’s assumption that the current length of patent reward is optimal from a social perspective, and
the patentee reward-monopoly loss ratio for every patent exploitation practice is to be compared to the ratio
implicit in the last year of patent term to see whether the same patentee reward can be obtained at a lower
monopoly loss. Kaplow, supra note 1, at 1826–29.
88
Ian Ayres & Paul Klemperer, Limiting Patentees’ Market Power Without Reducing Innovation
Incentives: The Perverse Benefits of Uncertainty and Non-Injunctive Remedies, 97 MICH L. REV. 985, 1008
(“All problems of patent regulation ultimately devolve to a question of government information. If
government had good information about the cost and/or consumer value of a particular information, it
could pay efficient lump-sum bounties to the inventor and be done with the ex post deadweight loss
altogether.”).
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commitment to paying the prize, or can be effectively prevented from reneging after the
fact, this system would be superior to the patent system, which incurs a deadweight loss
as a result of supra-competitive pricing. As Professors Ian Ayres and Paul Klemperer
observed, “[t]he current patent system—which grants the patentee a monopoly for a
limited number of years—is structured to minimize the government’s information
requirement.”89 The problem is that no one, including the government, possesses perfect
information and no one can accurately predict innovation costs in advance. The patent
system is our best option in light of this limitation.
¶46
To circumvent this problem of imperfect information, the patent system eschews
the task of estimating innovation costs ex ante altogether. It simply makes no attempt to
match patentee reward to innovation costs.90 What seems to have happened instead is
that patentee reward is roughly calibrated to the social value of innovation. For example,
under the principle of pioneering patents, groundbreaking innovations that open up a new
field of research or commercial development, which obviously create greater social
value, are entitled to broader protection than less significant innovations.91 Under the
doctrine of reverse equivalents, a technological improvement may escape literal
infringement if it represents a substantial progress from existing art. 92 Even the basic
patent doctrine of nonobviousness seems to reflect the value of the innovation as
indicated by its improvement from prior art.93 The extent of improvement from prior art
is one indication of the social value of an innovation; the greater the social value, the
more expansive the scope of protection. As Scotchmer noted, “[g]iven that the length
and breadth of patent protection cannot depend on the expected costs of an R&D project,
the only way to ensure that firms undertake every research project that is efficient is to let
the firms collect as revenue all the social value they create.”94 Given that the basic
parameters of patent protection, such as patent length and scope of patent rights, are set
ex ante, this may be the only feasible solution to the problem of imperfect information
within the patent system.95

89

Id.
LANDES & POSNER, supra note 7, at 300. Scotchmer, supra note 57, at 38. Scotchmer corroborates
this statement, observing that “[t]he private value of patent protection is linked to the social value of the
technology through market demand, but is not linked to firms’ research costs.”
91
Burk & Lemley, supra note 29, at 1656.
92
Id. at 1657-58. Burk and Lemley note that both doctrines have not been invoked by the Federal
Circuit, leading some to question their continual validity.
93
Id. at 1648-52; see also Robert P. Merges, Uncertainty and the Standard of Patentability, 7 HIGH
TECH. L.J. 1, 34–36 (1992).
94
Scotchmer, supra note 58, at 31. This of course does not mean that the patent system successfully
allow firms to appropriate the full social value of their innovations. As suggested previously, innovation
does create substantial external benefits that are not captured by its creators. What is suggested here is that
patentee reward is intended to capture the social value of innovation, not that it necessarily succeeds in
doing so.
95
Even if one were to accept that the lack of perfect information requires patentee reward to be
benchmarked against social benefits of innovation, the correct benchmark should be net social benefits, and
not gross social benefits. An innovation is only beneficial to society if it redounds net social benefits.
Therefore, patentee reward must take the full social costs into account. The innovator will naturally
consider private costs of innovation, but it will pay little heed to the external costs, such as consumer
welfare loss. In a system in which patentee reward is calibrated according to social benefits, some
mechanism must be devised to deduct the external costs from patentee reward. Only then will patentee
reward provide the socially efficient level of incentives.
90
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2. Critique of an Innovation Value-Based Approach
¶47

The focus of our inquiry is not the patent system as such, but how antitrust law may
adjust patentee reward by tightening or relaxing restrictions on patent exploitation.96 The
question is whether the antitrust courts use private costs or social value of innovation as
the basis of their decisions. At first glance, it seems to be the latter. The prevailing
judicial approach seems to be that so long as a patent exploitation practice does not
exceed the permissible scope of patent rights granted by the statute, it would generally be
upheld.97 If social optimality requires patentee reward to be benchmarked against
innovation costs instead of social value, and the patent system is prevented from doing so
because of imperfect information ex ante, the crux of our inquiry then becomes whether
the antitrust courts should perpetuate the suboptimal decision-making of the patent
system or embrace a different standard instead.
¶48
Two arguments can be made in defense of using social value of innovation as a
benchmark under the patent-antitrust rules. The first argument is the familiar one of
imperfect information. Just as the patent system is unable to determine innovation costs
ex ante, the antitrust courts will be equally incapable of doing so ex post. Therefore,
using social value of innovation as a benchmark is our only feasible solution. While this
imperfect information argument may apply to the patent system,98 it is less persuasive in
the antitrust context.99 Antitrust decisions are made in ex post proceedings that take place
after the innovation has been created and exploited. Innovation costs can be ascertained
with a reasonable degree of accuracy in ex post judicial proceedings.100 Once an
innovation has been completed, the R&D costs are ascertainable from the firm’s internal
accounting documents. Moreover, the antitrust courts have the capability to handle
complex calculations. They regularly do so with the sophisticated statistical and
econometric analyses presented in market definition and quantification of consumer
harm. Therefore, the information problem is considerably more surmountable ex post in
an antitrust proceeding than ex ante under the patent system.
¶49
In comparison, an accurate assessment of social benefits will be beset with
tremendous difficulty. The value of an innovation to a firm cannot be determined
independent of the market structure in which it operates. The amount of profit a firm can

96

While what ultimately rewards the innovator is not just the patentee reward, but the full private
benefits of innovation emanating from the variety of appropriation mechanisms, antitrust law exerts the
most direct impact on patentee reward. It has relatively less, or no, impact on the other means of
appropriation. Therefore, the discussion that follows will refer to patentee reward, ignoring the impact of
other private benefits of innovation for the time being.
97
See Brulotte v. Thys Co., 379 U.S. 29 (1964); see also CSU v. Xerox Corp., 203 F.3d 1322 (Fed. Cir.
2000).
98
In fact, this argument is not entirely apt even when applied to patent law itself. Although the general
parameters of patent protection are set by the statute ex ante, the courts can and do make adjustments to the
scope of protection and rights ex post. This is the essence of what Burk and Lemley call “policy levers” in
patent law. Burk & Lemley, supra note 29, at 1638-67. Even the standard of patentability is adjusted ex
post by the courts. Merges has argued that the doctrine of nonobviousness should be adjusted ex post to
take into account the R&D costs of innovation. Merges, supra note 93, at 34–54.
99
A related, but different, objection is that even if private costs of innovation could be accurately
calculated ex post, what matters to the decision to invest in an innovation is not these costs which are
ascertained ex post, but the expected costs of innovation arrived at by the firm ex ante. This argument will
be addressed subsequently.
100
Merges, supra note 93, at 55.
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make from an innovation depends on the existence of substitutes and competitors and
entry barriers, among other things. For example, in Baumol’s model of contestable,
oligopolistic markets involving routinized innovation, the value of innovation is said to
be equal to its marginal cost of production plus a depreciation charge that will allow the
firms to recover their R&D outlays.101 In addition to private benefits, social benefits of
an innovation include the benefits from follow-on innovations made possible by the
initial innovation. The full benefits of cumulative innovation will be difficult to ascertain
with a reasonable degree of accuracy. Social benefits become practically impossible to
measure accurately once one incorporates the spillover effects. Therefore, setting
patentee reward against the social value of innovation is unlikely to be feasible.
¶50
This leads one to wonder how the existing patent system undertakes this complex
exercise. The answer is that it does not. While the ostensible basis for patentee reward is
social value of innovation, the patent system makes only limited effort to adjust the scope
of patent protection to the social value of an innovation. As mentioned previously, some
patent doctrines offer greater protection to groundbreaking innovations. This is in some
way recognition of the importance of an innovation. The focus under these doctrines,
however, is not the innovation’s social value, but its technical merit. The standard is
usually by how much the innovation improves upon the prior art. While technically
meritorious innovations may have a greater chance of being social valuable, this
correlation is by no means certain. One can imagine a highly sophisticated egg-cracking
device that leaves no mess behind. It may be a substantial improvement from existing
egg-cracking technology, but its social value is likely to be limited.
¶51
The lack of a meaningful attempt by the patent system to ascertain the social value
of an innovation leaves open a distinct possibility that patentee reward may exceed its
social value. This would amount to overcompensation of the innovators and is
indefensible from a social welfare perspective. This is a further reason why antitrust
cannot rely on the scope of patent rights as a basis for deciding patent-antitrust cases.
The use of social value as a benchmark is beset with problems. The lack of a real attempt
by patent law to match the scope of protection to social value means that scope of patent
rights is a highly inaccurate benchmark for antitrust cases. Deciding patent-antitrust
cases with a view to preserving patentee reward will unlikely lead to socially optimal
outcome.
¶52
The second argument, which more generally applies to both the patent-antitrust
rules and the patent system, is that an innovator should be allowed to reap the full
benefits of her innovation. That is, the innovator should enjoy the benefits of what she
creates. This argument has great intuitive appeal. What can be more fair than reaping the
full value of one’s own labor? This argument also resonates with the Lockean labor
theory of property.102 Unfortunately, Lockean theory only applies to physical property
and there is no strong theoretical justification for allowing intellectual property owners to
appropriate the full value of their creations. Intellectual property law generally, and
patent law in particular, have always been justified on utilitarian grounds.103 Intellectual
property protection is offered to generate incentives, not to protect the value of one’s
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BAUMOL, supra note 6, at 187.
JOHN LOCKE, LOCKE’S TWO TREATISES OF CIVIL GOVERNMENT 314–15 (Peter Laslett ed., 1967).
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Burk & Lemley, supra note 29, at 1580.
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creation.104 This is clear from the language of the Constitution.105 Numerous
commentators have endorsed this incentive theory for patent protection. Professor
Edmund Kitch argues that “a patent should not be granted for an innovation unless the
innovation would have been unlikely to have been developed absent protection of a
patent.”106 Professor Robert Merges expresses a similar view that “[t]he conventional
ideal standard of patentability is that patents should only be awarded to those inventions
that would not have been made without the availability of the patent.”107 Burk and
Lemley observe that “[t]o a greater extent than any other area of intellectual property,
courts and commentators widely agree that the basic purpose of patent law is utilitarian:
We grant patents in order to encourage invention.”108 The notion that patentee reward
should reflect the social value of an innovation because an innovator should gain the full
value of its creation can only be justified by a just desert or reward theory of patent law,
which has been roundly rejected.109 If the goal of patent law is genuinely utilitarian,
patentee reward must be calibrated to the private costs of innovation.
¶53
The idea that patentee reward should only aim to cover the private costs of
innovation has also received considerable support. With respect to the determination of
optimal patentee reward, Boldrin and Levine note that “producers must be compensated
for their costs, thereby providing them with the economic incentive of doing what they
are best at doing. But they do not need to be compensated more than this.”110 Professor
Daniel Crane observes that “statutory innovation, legal doctrine, and judicial, executive,
and administrative practice have begun to cast intellectual property as a right to recover
the risk-adjusted costs of invention but not necessarily to exclude others from the
invention,”111 and that “[t]he optimal solution is the inclusion of those rights that grant
just enough reward to induce the incentive or creative activity at the lowest social cost
possible.”112 Merges’ proposed reformulation of the doctrine of nonobviousness—which
determines the breadth of patent rights—based on R&D cost consideration is also an
implicit recognition that patentee reward should be concerned with recoupment of
costs.113 In light of the overwhelming consensus on the utilitarian justification of the
patent system, and widespread recognition that patentee reward should only aim to cover
private costs of innovation, it is surprising that most patent-antitrust cases focus on the
preservation of the scope of patent rights and make no attempt to consider innovation
costs.
104

Crane, supra note 1, at 254 (“Intellectual property is incrementally moving away from the
conventional right of the landowner to fence out trespassers and toward a right to collect royalties from
constructive licensees.”); see also Bessen & Meurer, supra note 67, at 33–34 (noting doctrinal differences
between patent rights and real property rights).
105
U.S. CONST. art. 1, § 8, cl. 8 (“To promote the Progress of Science and useful Arts, by securing for
limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries.”).
106
Edmund W. Kitch, Graham v. John Deere, New Standards for Patents, 1966 SUP. CT. REV. 293, 301
107
Merges, supra note 93, at 19.
108
Burk & Lemley, supra note 29, at 1597.
109
Id. at 1597. Some commentators, however, have advocated a reward-based theory for patent
protection. See, e.g., A. Samuel Oddi, Un-Unified Economic Theories of Patents—The Not-Quite-Holy
Grail, 71 NOTRE DAME L. REV. 267, 275–77 (1996).
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BOLDRIN & LEVINE, supra note 20, at 128.
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Crane, supra note 1, at 254.
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Id. at 299.
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Merges, supra note 93, at 4.
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¶54

Setting patentee reward higher than private costs of innovation not only
overcompensates the innovators,114 but it also attracts rent-seeking behavior.115 Potential
innovators will expend considerable costs to obtain patent protection, as demonstrated by
patent races. Landes and Posner believe that the high incidence of failed drug
development projects is evidence of rent-seeking behavior by the large pharmaceutical
firms.116 The existence of substantial economic rent from patent protection has been
confirmed by Professors James Bessen and Michael Meurer. Economic rents are
supernormal or excess profits earned by patentees above the level of competitive returns.
They found that in 1999, the pharmaceuticals and chemicals industries earned $15.2
billion and other industries earned about $3.2 billion in patent rents in 1992 dollars.117
They further found that the annual rent per patent in the pharmaceuticals and chemicals
industries in 1999 was about $531,000, and that for other industries roughly $39,000 per
patent.118
¶55
The disproportionately high patent rent for the pharmaceuticals and chemicals
industries lends support to Landes and Posner’s intuition that at least some of the failed
R&D projects in the pharmaceuticals industry constitute rent-seeking behavior. This is
further confirmed by Professor F.M. Scherer’s observation that pharmaceutical firms tend
to increase their R&D expenditure following a rise in revenue. Their R&D expenditure
seems not to be determined by the number of promising technological opportunities, but
by the amount of cash that they have to spare. He argued that a competitive rent-seeking
model best describes the R&D agenda of these firms.119 Rent-seeking behavior is
particularly harmful in a differentiated market with competing patented products, which
characterizes many pharmaceutical markets.120 When there are numerous firms
competing for economic rent, and so long as competition does not completely eliminate
114

This windfall problem would be alleviated if we could somehow internalize all the social costs of
patent protection so that the innovator will take into both the social benefits and costs of its innovation
when making an innovation investment decision. However, there seems to be no effective means of doing
this. The inability to internalize social costs into the innovator’s investment calculus will most likely result
in excessive innovation.
115
LANDES & POSNER, supra note 7, at 300.
116
Id. at 315–16 (“The prospect of large profits enabled by patent protection provides a lure for
investment in research, yet the resources devoted to that research conceivably might be socially more
productive in an industry in which innovation is not rewarded with a monopoly.”).
117
BESSEN & MEURER, supra note 67, at 114.
118
Id. at 117. However, one may argue that this is not a meaningful comparison because the
correspondence between patent and product, or the patent to final product ratio, in the pharmaceuticals and
chemicals industries is probably lower than in other industries. One patent may already constitute one
product in the former two, whereas in other industries such as semiconductors, automobile or complex
machinery, thousands of patents may be needed to build one final product. Id. at 71 (semiconductors
require thousands of patents). These other industries are more patent-intensive in the sense that the creation
of one product requires the incorporation of a greater number of patented technologies. In a way, one may
even question how we should draw the meaningful boundary of a technology in different industries, and
whether the scope of a single patent is the correct one. A novel suspension system in an automobile is what
most of us would think of as one discreet technology, so is a new protease inhibitor for treating HIV. The
number of patents required to constitute each technology can be grossly different. A suspension system is
arguably not even a meaningful economic product in the eye of end consumers. Instead of counting
technology by the number of patents, there is a good argument that it should be done by the number of
discrete, independently functional technology.
119
F.M. Scherer, A Note on Global Welfare in Pharmaceutical Patenting, 27 WORLD ECON. 1127, 1136
(2004).
120
BOLDRIN & LEVINE, supra note 20, at 10.
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this rent, the rival oligopolists will produce too many similar items and this overproduction will offset much of the social surplus from innovation.
C. A Closer Look at the Private Costs of Innovation
1. Unrecoverable Sunk Costs vs. Fixed Costs
¶56

A number of issues pertaining to R&D costs remain to be addressed. The first one
is whether R&D costs are sunk costs that should be disregarded altogether in patentantitrust cases or whether they are fixed costs of production that need to be recouped in
order to preserve dynamic efficiency. Boldrin and Levine have argued that in a
competitive market, no extra legal protection is needed to allow a firm to recover its
R&D costs. They characterize R&D costs as the costs for producing the first unit,
asserting that “[s]ince only ideas embodied in people or products matter, the cost of
creation is the cost of producing the first unit. Such a ‘sunk cost’ is very ordinary in
economics, and poses no particular threat to perfect competition.”121 Baumol agrees that
if R&D costs were indeed sunk, the nonrivalrous nature of the consumption of innovation
means that any license fee that would prevent some users from adopting the technology
would be inefficient.122 This, however, is where their agreement ends. According to
Baumol, while the R&D costs for serendipitous innovation, which he understands to be a
one-time innovation that arises more out of luck than persistent effort, are sunk, the R&D
costs for what he calls routinized innovation are recurrent and should be taken into
account when determining the optimal patentee reward.123
¶57
The better view is that R&D costs need to be recouped. First and foremost, the
argument that sunk costs can be disregarded ignores the dynamic efficiency aspect of the
problem. Patent protection affects not only the present innovator, but also potential
innovators who will be deterred from pursuing R&D if they knew that they would be
denied recovery of their R&D costs. Second, even Boldrin and Levine admit that there
are situations in which ordinary competitive rent will be insufficient to induce innovative
activity.124 They believe that the subset of innovations to which this applies is small.
There are reasons, however, to believe that they may have underestimated the size of the
subset. Third, one may argue that patentee reward should aim to permit recoupment of
the R&D costs of even serendipitous innovation. This is not to suggest that they are
likely to be in the same magnitude as the costs of routinized innovation, yet it remains
true that serendipitous innovation often emerges in the context of a routinized innovation
project.125 A research team may have accidentally discovered a chemical that turns out to
be highly valuable.126 The team probably has incurred considerable costs to put itself in a
121

BOLDRIN & LEVINE, supra note 20, at 2–3.
BAUMOL, supra note 6, at 223–24.
123
Id. at 38-39 (Under routinized innovation, “tomorrow’s sunk costs are still entirely variable today,
and the fate of sunk outlays of the past is likely to affect any rational decision on the resources to be
devoted to innovation in the future.”). Routinized innovation refers to R&D activities that are “a regular
and even ordinary component of the activities of the firm.” Id. at 2. For more discussion of routinized
innovation, see Section Error! Reference source not found..
124
BOLDRIN & LEVINE, supra note 20, at 3.
125
Merges & Nelson, supra note 65, at 839.
126
Viagra is a prime example. See Ian H. Osterloh, The Discovery and Development of Viagra
(sildenafil citrate), in SILDENAFIL 1, 3 (U. Duzendorfer ed., Burkhauser Verlag 2004).
122
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position to make the accidental discovery. At least part of these costs should be
considered when determining the size of patentee reward.
¶58
Finally, if patentee reward is to be based on innovation costs, and yet R&D costs
are deemed to be sunk and unrecoverable, as argued by Boldrin and Levine, the necessary
implication would be the abolition of the patent system, which is the central thesis of
their book Against Intellectual Property. This is probably a step too far. What this
Article advocates is only a return to the utilitarian roots of the patent system and the use
of innovation costs as a reference point for the patent-antitrust rules when delineating the
permissible scope of patent exploitation.
2. Taking Risks of Innovation into Account
¶59

It is often argued that patentee reward needs to take into account the risks of
innovation. Innovation is a risky venture. Many R&D projects fail to produce any useful
product for the firm while incurring considerable costs. Prime examples are failed drug
development projects.127 The argument that patentee reward needs to take risks into
account usually comes in two forms: first, that the risk of a particular project needs to be
reflected in its reward so that expected returns, and not actual returns, from the project
are sufficient to cover its costs, and second, that patentee reward needs to allow firms to
cover the costs incurred in both successful and failed projects. If firms only make a
competitive return from successful projects while incurring wasted R&D costs from
failed projects, firms would be running at a loss and innovation would be deterred.
¶60
These arguments are certainly valid. There is no denying that the risks of
innovation must be considered when setting optimal patentee protection. However, it
cannot be true that patentee reward must both reflect the risks of individual projects and
cover the wasted R&D costs from failed projects. Doing so would amount to an
insurance against all failures in R&D, which would surely lead firms to take on excess
R&D risks and encourage the kind of rent-seeking behavior identified by Landes, Posner,
and Scherer. As valuable as innovation is to society, society cannot provide a safety net
for all failed R&D projects. Firms must bear the consequences of their failures in order
for the R&D decision-making process to remain efficient, at least from a private
perspective.128 A better approach to incorporating risks of innovation is to adjust the
patentee reward by the ex ante estimation of success rate. If an R&D project was
estimated to have a 50% success rate prior to its commencement, and private costs of
innovation turn out to be $1 million, the patentee reward should be raised to $2 million to
ensure that the innovator’s ex ante risks are reflected.129
127

Studies of pharmaceutical R&D estimate that if one were to screen 5,000 to 10,000 chemical
compounds for possible therapeutic value, roughly 250 of them will show sufficient promise for further
testing. Out of these 250 molecules, about five of them will be put through clinical testing. And 80% of
the drugs that are clinically tested end up in failure. JAFFE & LERNER, supra note 6, at 42. For more
information on the economics of R&D in drug development, see William S. Comanor, The Economics of
Research and Development in the Pharmaceutical Industry in PHARMACEUTICAL INNOVATION:
INCENTIVES, COMPETITION, AND COST-BENEFIT ANALYSIS IN INT’L PERSPECTIVE 54 (FRANK A. SLOAN &
CHEE-RUEY HSIEH EDS., 2007).
128
This process probably cannot be socially efficient because firms will not capture the full social
benefits of innovation, nor will they internalize the full social costs.
129
Boldrin & Levine, supra note 6, at 144–45 (taking risk into account does not fundamentally change
how innovation investment decision is made, but merely requires probability to be taken into account).
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A caveat is in order. It is easy to overstate the extent of failure in innovation.
Projects that do not produce readily commercializable products may generate useful
knowledge that turns out to be valuable in subsequent projects. Unintended outcome or
products emerge from R&D projects regularly. If the risks of failure are to be reflected in
patentee reward, the unexpected or incidental benefits of these projects should be counted
as well. These benefits should be deducted from the expected patentee reward.
D. A Proposed Approach to the Patent-Antitrust Interface

¶62

So what lessons does the foregoing discussion hold for resolving the patentantitrust conflict? An innovation would be beneficial to society if its social benefits
outweigh its social costs. If the contrary were true, society would be better off without
the innovation. This may suggest that the antitrust courts should attempt to determine the
social desirability of innovation. If an innovation fails to create social benefits, the court
should try to limit the scope of patent exploitation to such an extent that private benefits
of innovation are insufficient to cover its private costs. This would signal to future
innovators the need to undertake a careful evaluation of the net social benefits of their
R&D projects. The antitrust courts would help to restore the proper function of the patent
system and to ensure that only net socially beneficial innovations are pursued.
¶63
While that may be theoretically sound, it would be immensely difficult in practice
for the antitrust courts to arrive at a confident estimation of the social benefits of an
innovation, even if the exercise is done after the fact. The difficulty with ascertaining
social benefits has been alluded to earlier. Nascent technology compounds this difficulty.
Possible uses of the technology may not have been discovered at the time of the suit.
Therefore, even if the courts were able to derive accurate estimations of the total social
benefits and costs of an innovation at the time of the suit, they would still fail the exercise
by excluding possible future costs and, more importantly, benefits. If the courts
systematically underestimate the social benefits of nascent technologies, litigants
challenging a patent exploitation practice under antitrust law will be induced to bring
suits early in the life of a technology.
¶64
Moreover, to allow the antitrust courts to determine the social desirability of an
innovation and to roll back the incentives provided by the patent system would amount to
a usurpation of the patent system. Even if the courts were able to come to a correct
estimation in every case, it would introduce substantial uncertainty to corporate business
planning. A firm would stand to suffer great loss if it turned out to have been wrong
about the social costs and benefits of its innovation. The risks of innovation would be
magnified. And if the courts were to make mistakes in their judgment, which they are
bound to do, the costs of false positives would be enormous. In light of these serious
detriments of overreaching, the antitrust courts should assume innovations that have been
created as socially desirable and focus on calibrating patentee reward that would allow
the innovator to recover its innovation costs while maximizing net social benefits.
¶65
In patent-antitrust cases, antitrust law should strive to maximize net social benefits
while ensuring that private benefits of innovation cover innovation costs.130 One way to
130
Strictly speaking, the concern of the antitrust courts is that private benefits of innovation cover
innovation costs. However, the component of private benefits over which the courts exert the most direct
control is patentee reward. While legal rules certainly have impact on the other appropriation mechanisms,
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think of this task is as a problem of constrained maximization. The entity to be
maximized is net social benefits of an innovation, subject to the constraint that private
benefits exceed innovation costs. This approach merely represents a return to the
utilitarian roots of the patent system, which require patentee reward to be benchmarked
against innovation costs. The goal of patent protection is to provide innovation
incentives by ensuring that innovation costs are recovered. Since innovation costs
include both direct R&D costs and the opportunity cost of innovation, if patentee reward
slightly exceeds those costs, innovators should have sufficient incentives to innovate.
Hence the purpose of the constraint is to ensure that socially beneficial innovations
continue to be created.
¶66
Subject to the constraint that innovation costs are covered, the antitrust courts
should attempt to maximize net social benefits by reducing social costs and raising social
benefits.131 Patentee reward should be traded off for increase in net social benefits. To
the extent that patentee reward substantially exceeds innovation costs on a systemic basis,
there will be room for antitrust to trade patentee reward for greater social benefits without
undermining innovation incentives. This is where the maximization comes into the
picture. The handsome patent rents earned in some industries suggest that this is a
realistic prospect. The discussion thus far has focused on patentee reward because it is
the kind of private benefit that is most directly affected by the patent-antitrust rules. It is
important to recall the empirical evidence that the private benefits of innovation
significantly exceed patentee reward. This is because of the range of appropriation
mechanisms, such as first mover advantage and sales and marketing, at an innovator’s
disposal. In order to ensure that innovators are not overcompensated, the constraint
under the constrained maximization approach should be reformulated to refer to private
benefits as opposed to patentee reward. As long as the various kinds of private benefits
in aggregate cover innovation costs, innovation incentives will be preserved.
¶67
Theoretically, the constrained maximization approach could work in both
directions. It could either reduce or augment private benefits of innovation by adjusting
the scope of patent exploitation. The constraint prong only requires private benefits of
innovation to cover innovation costs; adjustments to patentee reward are not confined to
downward ones. If innovation costs are found to have exceeded aggregate private
the impact is usually more indirect and difficult to predict. Therefore, this Article will assume that the
principal focus of the courts on the private benefit side of the trade-off is patentee reward, while largely
taking the remaining private benefits as given.
131
In a way, this is similar to Kaplow’s model, in which he recognizes the need simultaneously to solve
the questions of the optimal scope of the patent-antitrust doctrine and the patent life. See Kaplow, supra
note 1, at 1839–42. When Kaplow poses the question of the optimal patent life, what he seeks to answer is
the optimal scope of patent protection. Under the constrained maximization approach, the optimal scope of
patent protection, which encompasses both patent term and scope of patent rights, is taken to be that
amount of protection which results in a patentee reward slightly exceeding innovation costs minus returns
from other appropriation mechanism. While Kaplow trades monopoly loss for patentee reward after a
systemically optimal patent life has been determined in advance, the constrained maximization approach
attempts to maximize net social benefits and determine the optimal patentee reward at the same time. The
reason for the difference in approach is that while Kaplow believes that it is possible to determine a
universally optimal amount of patent protection, and then use his patentee reward-monopoly loss ratio as a
guidepost to trade more freedom of patent exploitation for shorter patent term and vice versa, this Article
assumes that there is no universally optimal amount of protection. Given the diversity of industry and
technology covered by the patent system, it is not possible to adopt a one-size-fits-all approach and hope
that one optimal ratio will work in every industry and for every technology. The optimization exercise
must be done in every case.
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benefits, the innovator could conceivably request the court to relax the patent-antitrust
rules to allow it to recover innovation costs. There may even be concerns that patentees
with failed R&D projects may try to recoup its losses through opportunistic use of
antitrust suits.
¶68
When evaluating such a claim by the innovator, the courts should be mindful that
private benefits are not measured only up to the time of suit, but over the lifetime of the
technology. The court should only relax the scope of patent exploitation under the
constrained maximization approach if there is convincing evidence that the innovator will
not break even eventually. Moreover, while this may be a theoretical concern, it is
unlikely to be a serious one in reality. Past experience shows that patents that raise
significant antitrust issues are likely to be highly valuable. Private benefits for these
innovations are likely to be high and to exceed their innovation costs. Meanwhile,
patents for failed innovations are likely to be of low commercial value and are unlikely to
raise antitrust concerns. Therefore, the opportunistic use of antitrust suits to make up for
loss-making R&D projects should not be a matter of grave concern.
¶69
One advantage of the constrained maximization approach is that it avoids the pitfall
of the prevalent judicial approach that tends to examine a patent exploitation practice in
isolation. What the courts tend to do is to decide whether a particular exploitation
practice is within the scope of patent rights, however the rights are defined. It does not
matter how else the patentee has chosen to exploit is patent. A patentee may have
extended the term of royalty payment beyond the patent term, which was deemed illegal
by the Supreme Court in Brulotte v. Thys Co.,132 but at the same time may have refrained
from engaging in price fixing with its licensee-competitor under the well-known but
much-maligned GE exception.133 It may have exceeded the permissible scope with one
exploitation practice, but may have stayed clear of the limit with respect to another
practice. In the aggregate, the patentee may have reaped no more benefits than that
which is necessary to recover its innovation costs. Under the current judicial approach,
the extension of royalty payment beyond the patent term is deemed illegal, regardless of
the totality of circumstances. This approach overlooks the fact that the size of the
patentee reward is not determined by one patent exploitation practice, but by the overall
mix of exploitation practices employed by a patentee. As Crane observed, the legality of
a patent exploitation practice must be examined in light of the “bundle of rights” that a
patentee has chosen to exercise.134 By taking a holistic look at the social calculus, the
constrained maximization approach avoids this pitfall.
¶70
The holistic analysis required by the constrained maximization approach will need
to be undertaken within a Rule of Reason framework. It will be difficult to state a priori
whether a particular patent exploitation practice is pro-competitive or not. This should be
unproblematic because few commentators and courts advocate a per se approach to the
patent-antitrust interface. What may be unfamiliar to some within the antitrust circle is
the idea that the legality of one practice depends on the range of exploitation practices
adopted by the patentee. This unfamiliarity, or perhaps even unease, is in some ways
understandable because in few other areas of antitrust does the legality of one conduct
depend on the firm’s market behavior as a whole. This is almost the same as saying that
132

379 U.S. 29 (1964).
United States v. Gen. Elec. Co., 272 U.S. 476 (1926).
134
See Crane, supra note 1, at 256.
133
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resale price maintenance is illegal because the firm has pursued predatory pricing in the
relevant market, or perhaps even a different market. However, this interdependence is
the necessary consequence of the fact that the resolution of patent-antitrust issues is
essentially an optimization process. This is true in both Kaplow’s model and the
constrained maximization approach proposed in this Article. Optimization is necessary
because calibration of the appropriate scope of the patent-antitrust rules requires the
ascertainment of the optimal tradeoff between static and dynamic efficiencies. This
optimization rationale does not exist in other areas of antitrust law. Antitrust does not
strive to discover the optimal tradeoff between price and output for firms. Nor does it
attempt to strike a balance between producer and consumer surplus.
III. PRACTICAL APPLICATION OF THE PROPOSED APPROACH
A. A Simplification of the Constrained Maximized Approach
¶71

While a full-fledged constrained maximization approach would be the most
theoretically precise and comprehensive, it is unlikely that the courts would be prepared
equipped to consider such a wide range of interrelated and difficult-to-quantify factors in
their decision. Therefore, it is worth simplifying the analytical framework and focus on
the most important components to improve the administrability of the approach.
¶72
The external benefits of innovation include the direct benefits of a new technology
for society, the spillover effects, and the possibility of follow-on innovation built upon
this technology.135 The direct social benefits of an innovation are a key component of net
social benefits and should clearly be incorporated in the framework. These benefits
depend on two factors: the inherent technical contribution of the innovation in satisfying
a previously unmet consumer demand and the availability of the technology. The former
is unlikely to be affected, at least not directly, by the patent-antitrust rules.136 The latter
will be highly sensitive to the patent-antitrust rules. Stricter patent-antitrust rules will
improve the availability of the technology to consumers, which implies that it is likely to
be sold at a price closer to the competitive level.
¶73
The treatment of spillover benefits is more difficult. While spillover effects can be
substantial, restricting patent protection in order to increase them and facilitate imitation
would be a direct affront to the patent system. The quintessential patent right is the right
to exclude. Imitation can only be facilitated and spillovers augmented if this right is
dramatically curtailed. While consumers would no doubt be better off if more firms
could commercialize the technology and offer the product at lower prices, which is a
tradeoff that is best left to the patent system to make.

135

The social benefits of innovation, of course, consist of both external and private benefits. Similarly,
social costs of innovation consist of both external and private costs of innovation. The private benefits and
costs of innovation, however, need not be reconsidered here because under the constrained maximization
approach, private benefits are meant to be just sufficient to cover private costs. They are roughly
equivalent. We can thus take them both out of the consideration and focus on external benefits and costs.
136
It is conceivable that patent-antitrust rules may have such a direct and significant impact on patentee
reward, and assuming that patentee reward accounts for a large proportion of the private benefits of
innovation, that firms will make substantial adjustments to their R&D budgets accordingly. If we further
assume that the significant changes in R&D investments will affect the technical merits of innovation, then
the patent-antitrust rules may have indirect impact on the inherent technical contribution of an innovation.
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¶74

The situation is different for cumulative innovation. Here, the improver does not
simply replicate the innovator’s technology and undercut its profit margin. The improver
actually builds on the technology and creates new technologies or products out of it.
Given the substantial benefits of cumulative innovation, it should be retained in the
constrained maximization exercise.
¶75
As for the external costs of innovation, they include consumer welfare loss from
supra-competitive pricing and the costs of creative destruction. The costs of creative
destruction should be left out. While it is true that they impose real costs on society, they
seem to be an inevitable price to pay for technological progress. Assuming that these
costs were internalized by a monopolist producer in a market, which chooses not to
produce a new product because of the potential cannibalization of its revenue from
existing products, few would believe that this is a desirable state of affairs.137 This is
what Kenneth Arrow has described as the replacement effect, and is the main reason why,
according to him, competition is more conducive to innovation than monopoly. 138 By
incorporating the costs of creative destruction in the analysis, we may inadvertently slow
down competition in innovation.
¶76
Consumer welfare loss should be the main focus of the constrained maximization
approach, however simplified. After all, consumer welfare is the main policy concern of
antitrust law. Pared down to a more manageable set of variables, a simplified constrained
maximization should focus on maximizing net social benefits with due focus on
consumer welfare loss, the direct social benefits of innovation, and the benefits of
cumulative innovation.
B. A Further Simplification of the Approach
¶77

Even with the proposed simplification, the antitrust courts may still feel uneasy
about the suggested approach. The courts may feel ill-equipped to arrive at estimates of
the direct social benefits of innovation or the benefits of cumulative innovation. The
courts may feel uncomfortable with the idea of a direct trade-off between patentee reward
and the net social benefits of innovation. The courts may further feel unable to arrive at
an accurate estimate of the private costs of innovation, which include both R&D costs
and opportunity costs. Admittedly, the quantitative terms in which the constrained
maximization approach has been formulated thus far may be so far removed from the
structure of conventional legal doctrines that the courts may hesitate to adopt it.
¶78
This concern can be addressed if the constrained maximization approach were
reformulated in qualitative terms instead. The insights from the approach can be distilled
into a number of qualitative guidelines. For example, should the various private benefits
of innovation be too difficult to quantify, the courts can reinterpret the inquiry as how
important patentee reward is to this innovator’s ability to recoup its innovation costs. If it
is found that patentee reward is not particularly important to an innovator, the courts will
have greater leeway to minimize consumer harm and facilitate cumulative innovation.

137

Frederic M. Scherer, Technological Innovation and Monopolization 42 (Am. Antitrust Inst. Working
Paper No. 05-07, 2005) at 18–34 (arguing that AT&T withheld certain important innovations for fear of
cannibalization effect).
138
Kenneth J. Arrow, Economic Welfare and the Allocation of Resources for Invention, in THE RATE
AND D IRECTION OF INVENTIVE ACTIVITY 609, 619–20 (Nat’l Bureau of Econ. Research ed., 1962).
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Similarly, the courts can qualitatively determine in which industries and under what
circumstances cumulative innovation is likely to be especially beneficial to society.
Fortunately, empirical studies by economists have demonstrated trends by innovationtype and industry with respect to reliance on patent protection for innovation incentives,
importance of cumulative innovation, and other inquiries that will prove useful to the
courts in applying the constrained maximization approach.
¶79
What follows is a host of guidelines to help the courts apply the insights from the
constrained maximization approach. These guidelines focus on the nature, breadth,
depth, and source of the technology; the relationship between the technology and the final
product; the relationship between the technology and other related technologies; and the
industrial environment in which the technology is created. It should be clear that after
being reduced to these qualitative guidelines, the approach loses considerable precision.
Nonetheless, these guidelines should provide the courts with some helpful guidance on
how to apply an appropriate degree of scrutiny to verify innovation incentive arguments.
1. Types of Innovation
¶80

Economists have classified technologies along a number of different dimensions:
incremental innovation vs. radical innovation; general-purpose technology vs. specialized
technology; serendipitous innovation vs. routinized innovation; and, product innovation
vs. process innovation. These classifications focus on the different attributes of a
technology. As it turns out, these classifications provide helpful guidance on the
qualitative application of the constrained maximization approach.
i) Product Innovation vs. Process Innovation

¶81

The distinction of product vs. process innovation pertains to the nature of the
technology. A product innovation results in a new product that substantially improves on
existing products, drawing new demand from consumers. A process innovation improves
the production process of an existing product. Baumol defines a product innovation as
“one that shifts the demand curve for the affected final product to the right, while a
process innovation is one that shifts the pertinent cost curves downward.”139 The most
readily measurable benefit of a process innovation is the reduction of production costs.
The social benefit of product innovation is reflected by the additional amount that
consumers are willing to pay for the new product. Economists have repeatedly found that
product and process innovations exhibit varying degrees of dependence on patent
protection as an appropriation mechanism. Specifically, it has been shown in a number
of empirical studies that patent protection is a more important method of protecting
product innovation than it is for process innovation. In one of the most exhaustive
studies on the relative importance of different appropriation mechanisms, then-Professor
Richard Levin and his co-authors (the “Yale survey”) discovered that patents were
generally rated as the least effective appropriation mechanism for process innovations,
and that lead time, learning curve advantages, and secrecy were all deemed to be more
effective by R&D managers of major corporations.140 As for product innovations, patents
139
140
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were more effective than secrecy as an appropriation mechanism, but were substantially
less so than lead time, learning curve advantages, and sales efforts.141 80% of the
sampled businesses rated sales and service effort, as an appropriation mechanism, at 5.0
out of a 7-point effectiveness scale. Only 20% of the sampled businesses gave patents
the same effectiveness rating.142
¶82
These results have been corroborated by subsequent studies. In a 2000 update of
the Yale survey, Professor Wesley Cohen and his co-authors (the “Carnegie-Mellon
survey”) reached largely similar results as those obtained in the Yale survey.143
Revealingly, the Carnegie-Mellon survey found that direct profit is no longer the
predominant motive for patenting. The prevention of rivals from patenting related
inventions, the use of patents in negotiations, and the preemption of future infringement
suits are now more important motivations for doing so.144 Industry perceptions of the
relative effectiveness of patents as a means of protecting product and process innovations
have manifested themselves in patenting behavior. It has been estimated that large
European firms applied for patents on only 36% of product innovations and 25% of
process innovations.145
¶83
If the courts are able to arrive at fairly reliable estimations of the weight of patentee
reward in the aggregate private benefits of innovation, they would be able to determine
by how much patentee reward can be adjusted without undermining innovation
incentives. However, in the likely event that this proves elusive, the courts can determine
the relative importance of patentee reward as an appropriation mechanism based on the
type of innovation at issue. If the case involves a process innovation, the court can be
less concerned that reducing patentee reward would undermine innovation incentives. If
the court is confronted with a product innovation, as seems more frequently to be the case
from a quick survey of the leading patent-antitrust cases, it will need to proceed more
cautiously.146
ii) Incremental Innovation vs. Radical Innovation
¶84

The distinction between incremental and radical innovations reflects the depth of
the impact of the innovation. An innovation that has a deep impact on future

edition of The Economist contains an article about recent advancement in the use of carbon fiber materials
in automobiles. See Charles Babbage, A high-fibre diet, THE ECONOMIST ONLINE, Mar. 7, 2011, available
at http://www.economist.com/blogs/babbage/2011/03/carbon-fibre_composites&fsrc=nwl. The article
describes in detail the innovation in the manufacturing process that has allowed McLaren to mass-produce
sports cars that are much lighter and more maneuverable than their peers. This technology may
revolutionize how sports cars are made. Even McLaren believed that its competitors could imitate the
production technique from the knowledge they can glean from the article, it would be unlikely that it would
have disclosed its process innovation in such detail to the reporter.
141
Id. at 795.
142
Id. at 796.
143
See generally Wesley M. Cohen, Richard R. Nelson & John P. Walsh, Protecting Their Intellectual
Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not), NAT’L BUREAU
ECON. RESEARCH WORKING PAPER No. 7552 (2000), available at http://www.nber.org/papers/w7552.
144
Id. at 4.
145
BESSEN & MEURER, supra note 67, at 89.
146
However, even that may no longer be true. Cohen and his co-authors found that since the Yale
survey, secrecy has become the most important appropriation mechanism even for product innovations.
Cohen et. al., supra note 143, at 3.
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technological development and society in general would be considered a radical
innovation. Otherwise, it would be characterized as an incremental innovation.
Examples of radical innovation include the steam engine, penicillin, the airplane, and the
Cohen-Boyer patents on recombinant DNA technology that have essentially opened the
field of genetic engineering. Needless to say, most innovations are incremental.
However, the dichotomy between the two may not be as clear-cut as it would initially
seem. The depth of the impact of an innovation most likely varies along a spectrum.
Moreover, what seems like a radical innovation often consists of a number of incremental
innovations.147 A prime example is the steam engine, which has been said to consist of
numerous technical innovations by various inventors prior to James Watt, such as
Thomas Newcomen, who first created a functional steam engine in 1712.148
¶85
It should be obvious that radical innovations redound substantially greater social
benefits on society, both in terms of direct benefits and the possibility of follow-on
innovation. Without attempting to quantify the precise magnitude of the direct benefits,
the courts should be able to conclude that a patent exploitation practice that restricts
consumer access to a radical innovation will inflict considerable welfare loss on society.
Similarly, a patent exploitation practice that limits other innovators’ access to the
technology for possible follow-on innovations will deny society the substantial benefits
of improved utilization of the radical innovation. This is especially significant from a
social welfare perspective because many radical innovations require subsequent
incremental ones to be successfully commercialized.149
¶86
The obvious objection is that by facilitating follow-on innovation and
commercialization by other innovators, the courts will undermine the incentives of the
original innovator to do the same. This is reminiscent of Kitch’s prospect theory on
patent protection, the key underlying assumption of which is that the original innovator
possesses the best capability and the greatest incentives to undertake the follow-on
innovations. This assumption will be examined at greater length later. Suffice it for now
to say that a number of leading commentators of intellectual property have challenged
this assumption.150 It would be a mistake for the antitrust courts to sacrifice possible
follow-on innovation by rival innovators in the name of a theory of questionable validity.
iii) General-Purpose Technology vs. Specialized Technology
¶87

Related to the incremental vs. radical innovation distinction is the classification of
general-purpose technology (“GPT”) and specialized or non-general-purpose
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technology.151 Examples of GPT include electricity and computer.152 A recent addition
of GPT is three-dimensional printing, which allows one to produce a three-dimensional
object from scratch. According to The Economist, it is likely to revolutionize the
manufacturing industries by allowing just about anyone to create a complex object at
home. This emerging technology is expected to “reset the economics of manufacturing.
Some believe it will decentralise the business completely, reversing the urbanisation that
accompanies industrialisation.”153 Whether a technology is general-purpose or not is
related to its breadth, in particular, its range of applications. A GPT is a technology that
has a wide range of possible applications. A GPT is likely to be radical and redounds
considerable benefits for society. The above discussion concerning how the antitrust
courts should take into account the radical nature of an innovation thus equally applies to
GPT. However, a radical innovation need not be general-purpose. AZT, the first drug
that was effective in retarding the replication of HIV, was no doubt a radical innovation.
Its range of application, however, is rather limited.
¶88
While much of the discussion about GPT in the academic literature has focused on
its contribution to economic growth, the breadth of a technology may also have
implications for the patent-antitrust interface. Here, it is necessary to invoke the intuition
behind Frank Ramsey’s theory on optimal commodity sales tax.154 Ramsey argues that
the optimal way to achieve a certain sales tax revenue target is to levy it on many goods
as opposed to concentrating the tax incidence on one good. Here, the idea is that with
respect to a GPT, society would be better off if innovation costs are recouped from a
wide range of applications as opposed to a few of them. The welfare loss would be
considerably smaller. Restricting the patentee reward of the innovator from one
application would not undermine innovation incentives so long as the patentee could
recover the shortfall from other applications. And the aggregate social welfare loss
would be smaller than if the patentee attempted to recover its innovation costs from one
application alone. Multiple-channel recoupment is only possible if the technology has a
broad range of applications. That would be the case for GPT. Therefore, when facing an
antitrust case involving a GPT, the courts should display greater readiness to trade
patentee reward for gains in social welfare. In fact, it would serve social good for the
courts to steer the patentee to diversify its recovery channels by restricting its patent
exploitation practices within each application.
iv) Serendipitous Innovation vs. Routinized Innovation
¶89

This distinction pertains to the source and the process of innovation. It refers to the
source of inspiration for innovation and how the process of innovation is managed. Ideas
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for serendipitous innovation come from unexpected and unpredictable sources.155
Serendipitous inventions may happen accidentally or follow a flash of genius. They do
not come about simply because a firm devotes all the resources at its disposal to a
technical challenge. They may be produced by innovators of all shapes and sizes, from
individuals to small firms to multinational corporations. Meanwhile, routinized
innovation is largely the province of large corporations. The routinization of innovation
is the standardization and regularization of the innovative process. 156 It transforms
innovation from “a fitful and uncertain discovery process into something closer to a
routine internal matter governed by the bureaucratic and managerial procedures that also
control many of the other activities of the large corporation.”157 Serendipitous innovation
has been responsible for some of the most important inventions and discoveries,158 while
routinized innovation focuses on incremental improvement in product quality, reliability,
and user-friendliness.
¶90
For our purpose, the most relevant characteristic of routinized innovation as
opposed to serendipitous innovation is that the former is much less uncertain. By
regularizing innovation activities, and by performing R&D on a regular basis and in a
sufficient amount, routinization “increases the likelihood that some successful
innovations will emerge at reasonably regular intervals.”159 The relatively low
uncertainty for this type of innovation means that the adjustment that needs to be made to
private benefits to reflect the risk of innovation will be smaller. Another conclusion of
Baumol’s concerning routinized innovation also has important implications for the
patent-antitrust interface. He argues that in a contestable, oligopolistic market with low
barriers to entry, firms will not make any more than normal profit plus depreciation
contributions that will allow them to recover their R&D investment outlays.160 This
would imply that for these firms, patentee reward is barely sufficient to cover innovation
costs. Assuming that other sources of private benefits are small, there will be little room
for the courts to tinker with patentee reward without adversely affecting innovation
incentives.
2. Correspondence Between Technology and Product Boundaries
¶91

The correspondence between technology and product boundaries focuses on the
relationship between an innovation and its eventual commercial manifestation. It refers
to the fact that while some products, such as drugs, consist of one or a handful of
technologies,161 other products, such as most consumer electronics, electrical appliances,
complex machinery, automobile, etc. are made up of hundreds or even thousands of
technologies. To put it slightly differently, the technology and product boundaries for
innovations such as drugs coincide, while the two boundaries for consumer electronics
and machinery do not. As Burk and Lemley noted, “[m]uch of the conventional wisdom
155
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in the patent system is built on the unstated assumption of such a one-on-one
correspondence.”162 The presumed direct correspondence between innovation and social
welfare applies to discrete innovations such as pharmaceuticals. For technologies that
demonstrate considerable complementarity, such a direct relationship can no longer be
presumed. These technologies would only be socially beneficial if they could be utilized
together with their complements.
¶92
The most important implication of technological complementarity for the patentantitrust interface is that the ability of an innovation to create value for society crucially
depends on the availability of other complementary technologies. Should the owner of
one of the technologies decides to withhold its own contribution, many other
technologies will be rendered useless and society will stand to lose tremendous value.
This was vividly illustrated in the Blackberry saga when NTP, Inc., the owner of one of
the patented technologies in Blackberry, threatened to shut down the whole Blackberry
service.163 It was eventually able to extract more than $600 million of damages from
RIM, the developer of Blackberry.164 This saga was also a painful reminder of the
possibility of holdup for complementary technologies. When dealing with these
technologies, the antitrust courts must be mindful of the enormous loss of social benefits
that may result if one patentee is allowed to hijack the entire product by opportunistic
behavior.
3. Cumulative Innovation
¶93

Cumulative innovation concerns the relationship between the initial innovation and
future technological development, or more specifically, the follow-on innovation that
may be developed based on the initial innovation. Cumulative innovation would not be
an issue at all if the initial innovation were a dead-end technology that could not be
further improved upon. In reality, however, very few technologies belong to this
category. Paper clips, which were at one point patented, come to mind, although even
they have been improved upon by encasement of the metal with plastic.165 Most
technologies, meanwhile, carry considerable potential for substantial improvement.
Bicycles, which when first invented in the nineteenth century were fairly simple
machines, have been substantially enhanced in the ensuing years through the deployment
of new materials such as carbon fiber and advancement in mechanics. 166 The importance
of cumulative innovation for technological progress has been affirmed by numerous
scholars.167 Industries for which cumulative innovation is particularly important include
biotechnology, computer software, and computer hardware, some of the pivotal industries
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to the modern-day economy.168 Scholars have also noted that overly expansive patent
protection retards cumulative innovation.169 The challenge for the patent-antitrust
interface is to facilitate the development of subsequent improvements while ensuring that
the initial innovators are adequately compensated for their innovation costs.
¶94
Before delving into this policy challenge, the first question we need to answer is
whether the initial innovators or the rival innovators are best positioned to come up with
new improvements. The policy challenge would be much less severe if the initial
innovators were in most cases better equipped to improve the initial technology, or at
least to locate innovators who are able to do so. The challenge would become
considerably more complex if the sources of improvement were often unexpected and
unpredictable, defying coordination by the initial innovator. From a social perspective,
the policy challenge is two-fold: first, society would want to secure the improvements so
long as they redound net social benefits, and second, society would want to minimize the
costs of creating these improvements. Specifically, society would want to avoid
duplicative R&D by competing innovators pursuing the improvement. The detriment of
duplicative R&D is exacerbated by the lack of an independent invention defense under
patent law. Once an improver has secured a patent for an improvement, its rivals will be
barred from practicing that improvement even if they had independently created it.
¶95
Views on this dual policy challenge have largely fallen into two camps. Edmund
Kitch, the leading proponent of the prospect theory, believes that the initial innovator is
best positioned either to come up with further improvements or to identify innovators
able to do so. To Kitch, the main purpose of the patent system is not to provide
incentives for innovation, but to encourage further commercialization of existing ideas
and the exploration of improvements by granting prospective property rights over these
as yet undiscovered ideas.170 The initial innovator is hence tasked with coordinating
commercialization of the existing innovation and the search for further improvements,
with a view toward avoiding duplicative investments. If this view was correct, antitrust
law should refrain from interfering with patent exploitation, at least as pertaining to
cumulative innovation, since whatever licensing decisions taken by the patentee can be
presumed efficient. Patentees would be presumed to know best how to commercialize
and pursue further improvements. The prospect theory would hence leave a very limited
role for antitrust to police patent exploitation practices, at least in relation to licensing.
¶96
Unsurprisingly, subsequent commentators have challenged Kitch’s rosy view of the
efficiency, if not omniscience and good faith, of the initial innovator. Critique of the
theory has come from a variety of angles. First, it has been questioned whether the
innovator is truly better positioned to pursue improvements than his rivals. Even if the
innovator and its rivals were equally capable of producing improvements, the odds still
hugely favor the rivals due to their numerical advantage.171 For the incumbent innovator
to out-innovate all its rivals, its technical edge over them would have to be enormous.
Second, from a practical perspective, it has been argued that even if the initial innovator
possessed perfect information to identify the most appropriate improver, the initial
168
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innovator would still incur considerable transaction costs in order to reach an agreement
with the improver.172 Negotiating a licensing agreement can be enormously timeconsuming and costly for the innovator. And transaction costs are not confined to the
innovator’s identification and negotiation with potential improvers. It is entirely possible
for an improver to come up with a significant improvement to the initial innovation not
knowing that the innovation is patented. The improver will then need to identify the
patentee and negotiate with it. This task will be even more arduous if the improvement
implicates more than one patent, as is often the case.
¶97
Transaction costs are compounded by the problem of uncertainty. Negotiating an
agreement in light of the considerable uncertainty in technological improvement will
necessitate higher transaction costs. The uncertainty would be reduced, if not eliminated
altogether, if the innovator and the improver begin negotiations after the improvement
has been made. There would be no more uncertainty about the success of the
development of the improvement. However, ex post negotiations expose the improver to
potential holdup by the innovator, especially if the improvement falls squarely within the
scope of the initial patent. Commentators have noted that efficient negotiations over
technological development must take place ex ante to avoid strategic behavior on the part
of the initial innovator, which will result in under-compensation of the improver and a
socially sub-optimal level of improvement.173
¶98
The more fundamental critique of the prospect theory is the unrealistic assumption
of perfect information on the part of the innovator. Many commentators have argued that
new ideas are likely to spring up from various, often unexpected, sources. It is almost
impossible for a central planner lacking perfect information to identify all the
possibilities. Under the evolutionary model of innovation, innovation is “best understood
as a quasi-Darwinian process—a process almost of trial and error in which the market
selects from among diverse approaches whose relative promise cannot be assessed in
advance. This approach implies that a multiplicity of sources of inventive activity is
superior to a centralized process directed by the patentee.”174 If one subscribes to this
view of innovation, it seems obvious that the prospect theory will lead to a sub-optimal
level of improvement. Merges and Nelson have argued that it is to be expected that “a
single rightholder . . . underdevelop—or even ignore totally—many of the potential
improvements encompassed by their broad property right.”175
¶99
The obvious response to the evolutionary model is that theoretically speaking, there
is no difference between having ten firms vying for innovation in an industry as opposed
to unifying all these ten firms into one and having them operate as separate research
divisions. Unfortunately, there are reasons to believe that the two scenarios are not
equivalent and that inter-firm diversity would be more conducive to innovation than
intra-firm diversity.176 Managerial diseconomies impose a limit on how large a firm can
grow before its management can no longer keep abreast of its internal operations and

172

Economics of Improvement, supra note 68, at 1053–55.
SCOTCHMER, supra note 12, at 146-47; Daniel G. Swanson & William J. Baumol, Reasonable and
Nondiscriminatory (RAND) Royalties, Standards Selection, and Control of Market Power, 73 ANTITRUST
L.J. 1, 7–10 (2005).
174
LANDES & POSNER, supra note 7, at 318.
175
Merges & Nelson, supra note 65, at 873–74.
176
LANDES & POSNER, supra note 7, at 318–19.
173

425

NOR THWESTERN JOURNAL OF TECHNOLOGY AND INTELLEC TUAL PROPER TY

[2013

further internalization of outside productive activities becomes inefficient. A firm that
encompasses the innovative capacity of an entire industry is likely to have gone beyond
that point.
¶100
The prospect theory presumes rational behavior on the part of the innovator.
Lemley has questioned this presumption, arguing that the initial innovator may
irrationally eschew licensing for non-economic reasons.177 It may be due to a bitterly
fierce rivalry between two competing firms. It may be due to distrust of a rival’s good
faith to abide by the licensing agreement. It may be due to fear, rational or irrational, that
the licensed technology will somehow assist rivals in ways that are unforeseen by the
innovator. For example, the Wright brothers steadfastly refused to license their patents
on aircraft technology to anyone, and actively brought litigation against other aircraft
developers.178 In fact, it took a war (the First World War) and intervention by the
Secretary of the Navy to break this gridlock and bring all the related patents together so
that their complementary technical potential could be fully exploited. Meanwhile, there
was no government intervention to overcome the personal animosity between Guglielmo
Marconi, the patent holder for the diode technology—a crucial component of the early
radio—in the U.S., and Lee de Forest, the inventor of the triode, which was a significant
improvement over the diode.179 Their failure to settle their differences withheld from the
world the benefits of this significant improvement for years.180 These anecdotes lend
support to Lemley’s assertion that proponents of the prospect theory have a misplaced
faith in the knowledge, rationality, and good faith of the innovator to serve the social
good.181
¶101
All these arguments lead to the inevitable rejection of the prospect theory. In a
way, the debate between the proponents and the opponents of the prospect theory is
reminiscent of the long-run conflict between patent and antitrust. It may be recalled that
while the fundamental belief of antitrust is that competition generates more innovation
over the long run, patent law seems to hold the contrary Schumpeterian view. It was
argued then that the abiding faith of antitrust in competition means it prefers rivalry over
exclusivity in innovation. Here, we are facing the same dilemma. The aforementioned
theoretical arguments notwithstanding, whether the initial innovator or potential
improvers are best positioned to generate improvements is ultimately an empirical
question, the answer to which will perhaps remain elusive for quite some time. In the
end, absent overwhelming evidence and arguments negating the merits of competition,
antitrust should favor competition over exclusivity. And the evidence and arguments in
support of the prospect theory are far from overwhelming. Finally, Kitch himself admits
that prospect rights may create substantial market power and may result in supracompetitive pricing.182 While he identified the problem, he offered no solution for it.183
Given the focus of antitrust on consumer welfare, this probable consumer harm further
militates against the prospect theory.
177
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¶102

A rejection of the prospect theory means that competition among potential
improvers takes on added importance. Follow-on innovators must have sufficient
technological access to allow them to develop their improvements. At the same time, it
remains important to preserve the incentives of the initial innovator. The dual policy
challenge highlighted earlier presents an inevitable internal conflict. The question is how
should the balance be struck between these conflicting considerations. This question is
particularly important for the patent-antitrust interface because of the considerable social
benefits of cumulative innovation.
¶103
While antitrust needs to take an active role in securing the benefits of cumulative
innovation, especially in situations where patent law does not provide the appropriate
solution, it remains to be seen how it should be done. Economists distinguish three
scenarios of cumulative innovation: first, where an initial innovation spawns numerous
follow-on innovations; second, where many initial innovations, mostly in the form of
research tools, are needed to create a single second-generation innovation; and third,
where the subsequent innovation represents an improvement of the initial one and yet the
two compete with each other.184 The second and the third scenarios have been called,
respectively, the “anticommons” and the “quality ladder” models of cumulative
innovation.185 This author will call the first scenario the “trunk-branch” model for lack of
a better name in the literature. The three scenarios present disparate challenges for the
patent-antitrust interface.
¶104
Of all three models, the quality ladder model probably presents the least pressing
need for antitrust intervention. If the improvement is a radical one, it may benefit from
the doctrine of reverse equivalents and escape infringement. To the extent that an
innovation issue can be resolved internally within patent law, that solution is to be
preferred. Even if that doctrine or other patent internal solutions are unavailable, antitrust
still must proceed cautiously. There are a number of reasons for this. First, in most
quality ladder scenarios, subsequent improvements directly compete with the initial
innovation. This competition will allow the improver to erode the innovator’s profit,
which may be essential to the innovator’s recoupment of its innovation costs. In fact, the
erosion of profit might be so severe that future innovators will lose their incentives to
innovate. Second, it would seem that the denial of the improvement would not deprive
society of a product altogether; it would only leave us with a less advanced version of it.
This scenario is different from the other two scenarios where denied access to the
innovator’s technology may preclude the creation of subsequent products altogether.
Given that the first-generation technologies in those two models are often basic science
research or research tools such as gene fragments, from which society derives no direct
benefit, the development of second-generation products is doubly important to society.
Moreover, as previously pointed out, the welfare effects of a product innovation are
ambiguous. By choosing to interfere to facilitate the improver’s access to the innovator’s
technology under the quality ladder scenario, it is conceivable that antitrust may be
responsible for lowering the private benefits of innovation without producing any net
social benefits.
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¶105

Under the trunk-branch model, the beneficial social effects of the widespread
utilization of the “trunk” technology are significant. So long as the initial innovator is
compensated for its innovation costs, antitrust should facilitate technology diffusion.
This is particularly so because the technology has a myriad of applications. However,
given that many of the trunk technologies belong to basic scientific research, which have
no independent commercial value, licensing to second-generation users would be the
primary means of recouping the innovator’s costs. Here, the Ramsey intuition is again
relevant. From a social welfare perspective, society would be better off if the innovator
distributed its cost recovery among a wide range of uses, while minimizing the
distortionary effect within each use. The patent-antitrust rules should reflect this by
limiting the scope of patent exploitation, so that the innovator can be steered to diversify
its recovery channels.
¶106
The term “anticommons” was originally coined by Professors Michael Heller and
Rebecca Eisenberg in 1998 as a play on the term “commons.”186 Anticommons present a
particularly tricky situation because of the significant possibility of holdup by any one of
the owners of the research tools. Private parties often resolve the situation themselves
through patent pools or packaged licensing.
This is another version of the
complementarity problem that was mentioned previously. There it involved a number of
components going into a final product and here a number of complementary research
tools needed for further research and production of second-generation products. It was
argued then that antitrust has a robust role to play to minimize instances of holdup. The
same conclusion applies here.
4. Appropriability Conditions in the Industry
¶107

Appropriability refers to the conditions of an industry that allow the innovator to
reap the economic benefits of its innovation. It “summarizes the possibilities of
protecting innovations from imitation and of reaping profits from innovative
activities.”187 As discussed in Section Error! Reference source not found., there is a
whole range of appropriation mechanisms at the innovator’s disposal to allow it to profit
from its innovation. To the extent that an innovator relies on other appropriation
mechanisms, patentee reward will become relatively less important. In fact, Mansfield
and Levin conclude that in many industries, patent protection was not even necessary to
attract innovation.188
¶108
Economists have discovered that firms in different industries rely on patent
protection for innovation incentives to varying extents. Levin and his co-authors
classified the one hundred manufacturing industries surveyed in their study into three
clusters.189 The first cluster, consisting of food products and metal products among
others, does not seem to rely on any particular appropriation mechanism except for sales
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and marketing.190 The second cluster depends on a wider range of appropriation
mechanisms, such as first-mover advantages, learning curve advantages, and secrecy.
The third cluster, which includes pharmaceuticals and chemicals, is the only group that
utilizes patent protection extensively. These results are consistent with Mansfield’s
findings, which show that patent protection plays a much more important role in
appropriating returns in the pharmaceuticals and chemicals industries than in electronics
and machinery.191
¶109
These findings can be used as a basis for the courts to determine how much
patentee reward can be traded off for net social benefits in a particular industry. This is
especially useful if quantitative determination of the weight of patentee reward relative to
overall private benefits of innovation cannot be made. For example, when faced with a
patent-exploitation practice arising in a first-cluster industry, the courts can be less
concerned about preserving innovation incentives and pay closer attention to welfare loss.
The relative lack of reliance on patent protection will give the courts more room for
restricting the scope of patent exploitation under antitrust law without undermining
innovation.
5. Summing Up
¶110

The foregoing discussion is not meant to provide exhaustive guidance for every
type of patent-antitrust case. What the practical guidelines in this Section are meant to do
is to highlight the most relevant issues for the antitrust courts to consider in a patentantitrust case. The central message is that while the courts should remain mindful of
maintaining innovation incentives, achievement of that goal does not require complete
deference to patent rights. Given that innovation incentives are preserved whenever
innovation costs are covered, and that patentee reward is but one of the myriad
appropriation mechanisms available to innovators, there is in fact significant leeway for
the courts to protect and advance social welfare without undermining innovation
incentives. So long as innovative incentives are unaffected, the antitrust courts should
aim to maximize net social benefits, which can be accomplished by enhancing social
benefits or reducing social costs, or both. The focal points are the facilitation of
cumulative innovation and the minimization of consumer welfare loss.192
¶111
Consumer welfare has always been a central concern of antitrust. However, when
facing a patent-antitrust case, the antitrust courts often seem too ready to defer to patent
policy for fear of undermining innovation incentives. One of the main goals of this
Article is to clarify our understanding of innovation incentives and to reveal the
excessively pro-patent bias of the conventional wisdom. Two leading commentators
190
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deal is a direct affront to private property, the imposition of a duty to license absent any independent
antitrust violation, solely to facilitate spillovers, has close to no chance of acceptance in the antitrust circle.
Hence, this Article will not pursue this idea.
191
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have noted that “[l]egal scholars have failed to appreciate that unconstrained monopoly
pricing is not a cost-justified means of rewarding patentees.”193 In light of this improved
understanding of innovation incentives, it would seem that reluctance to tinker with
patentee reward can no longer be justified in the name of preserving innovation.
The importance of cumulative innovation has not been as widely recognized within
the antitrust circle as it has by patent law scholars. Given its importance in generating
economic growth, antitrust should pay closer attention to it. Antitrust professes to take
dynamic efficiency considerations seriously, but thus far it seems to have done so only
with a certain subset of those considerations, namely the provision of incentives for the
initial innovation.
Other dynamic efficiency considerations have been largely
overlooked. This is a grave mistake. Rectifying this mistake will require the antitrust
courts to make some difficult judgments. However, there is no reason to believe that it is
beyond the capability of these courts.
A further message of the foregoing discussion is the need for the courts to
distinguish between different types of innovation in different industries. As has been
repeatedly pointed out by patent commentators in recent years, not all innovations are the
same. There is a high degree of heterogeneity among innovations that the antitrust courts
need to consider. These distinctions include the nature, breadth, depth, and source of
innovation; its relationship with the final product; and its relationship with other
technologies. Lemley advocated an industry-specific approach to the patent-antitrust
interface.194 This Article asks the courts to go one step further and focus on the various
attributes of the technology at issue. These attributes will help the courts predict the
effects of its decision on the various parameters in the constrained maximization exercise.
Lastly, it is important to clarify that this Article does not advocate drastic
restrictions of patent rights. While some of the theoretical discussions in Section Error!
Reference source not found. suggest that patentee reward can be dramatically reduced
without undermining innovation incentives (assuming that private benefits of innovation
under the current patent system significantly exceed innovation costs for most
innovations), which may lead the reader to surmise that this author advocates aggressive
curtailment of patent rights by antitrust, the extent of intervention proposed in this Article
is much more modest. Substantial improvement of net social benefits can be achieved
with minor restrictions of patent rights. As Ayres and Klemperer observe, “[t]he last bit
of monopoly pricing produces large amounts of deadweight loss for a relatively small
amount of patentee profit.”195 Thus, small restrictions of patent rights and monopoly
pricing will not significantly undermine innovation incentives.
The theoretical discussion in Section Error! Reference source not found.
admittedly lends support to more substantial modifications of patentee reward. From a
social efficiency perspective, such modifications may be desirable. That, however,
would be a usurpation of the fundamental tradeoff between static and dynamic
efficiencies struck by Congress in designing the current patent system. As crudely as that
193

Ayres & Klemperer, supra note 88, at 987.
Industry-Specific Policy, supra note 13.
195
Ayres & Klemperer, supra note 88, at 987. This is so because of the offsetting gains in profit as a
result of a decrease in price (and the resultant increase in quantity sold). The resultant loss in patentee
profit should be small. Meanwhile, the improvement in social welfare, in the form of elimination of
deadweight loss, can be substantial. Therefore, inducing infringement to cause a small drop in price would
be socially efficient.
194
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tradeoff was struck, any major changes to it should be made by Congress, and not the
courts. Calls for reform of the patent system and rollback of the increasingly expansive
patent rights abound.196 There is ample evidence that the patent system as it currently
operates is broken.197 Yet, these defects of the patent system do not justify massive
interference on the part of antitrust law. Patent law’s problems remain its own to solve.
Drastic alterations to patent rights should not be made by the antitrust courts.
IV. AN APPLICATION OF THE PROPOSED APPROACH: UNILATERAL REFUSAL TO LICENSE
¶116

To demonstrate the application of the proposed approach, this Section will focus on
how it applies to the analysis of a unilateral refusal to license a patent. 198 Unilateral
refusal to license a patent is one of the most controversial areas of the patent-antitrust
interface. To those staunch defenders of intellectual property rights, imposing a duty to
license on a monopolist patentee constitutes a direct affront to private property. In some
ways, compulsory licensing has become a taboo in the U.S. antitrust circle.199 Mention of
compulsory licensing seems to be greeted with skepticism, if not derision.
¶117
The most common defense against imposing a duty to license is that it will
undermine innovation incentives. The conventional wisdom is that if an innovator is
forced to share its creation with competitors, it will be less likely to invest in innovations
in the future. Other innovators will be similarly deterred. By refusing to order
compulsory licensing, the courts will effectively force rivals to develop their own
196

See, e.g., JAFFE & LERNER, supra note 6, at 178–205 (making detailed and varied proposals for patent
reform); BESSEN & MEURER, supra note 67, at 235–53 (suggesting ways to improve notice function of
patents); BOLDRIN & LEVINE, supra note 20, at 23–67 (advocating abolition of patent system altogether).
197
JAFFE & LERNER, supra note 6, at 25–77; BESSEN & MEURER, supra note 67, at 46–94.
198
Hovenkamp distinguishes four types of compulsory licensing scenario: (1) concerted refusal to
license; (2) conditional refusal to license (such as tying and exclusive dealing); (3) compulsory licensing
imposed as a remedy for an independent antitrust violation; and, (4) unilateral refusal to license as an
antitrust violation itself. This Article will focus on the last two instances. The competitive harm of a
concerted refusal to license stems mainly from the concerted aspect of the conduct rather than the denial of
access to a patented technology. It does not raise as immediate concerns about innovation incentives as the
other instances of compulsory licensing. Conditional refusal to license, it is argued, is better analyzed
under the rubric of the alternative characterizations. This is because the doctrine and the economic
understanding about conduct such as tying and exclusive dealing seems to be more sophisticated than that
concerning unilateral refusal to deal. Analysis under that rubric is likely to be better informed. Moreover,
treating conditional refusal to license as instances of tying or exclusive dealing carries the added benefit of
avoiding the stigma that is usually attached to compulsory licensing within antitrust law. It will probably
help to allow the courts to approach the issue in a more objective manner. However, given the dearth of
refusal to license cases that belong to these last two categories, cases falling under the first two may be
discussed where relevant.
199
For a general view within the literature on unilateral refusal to license and compulsory licensing and
the related doctrine of essential facilities, see Howard A. Shelanski, Unilateral Refusal to Deal in
Intellectual and Other Property, 76 ANTITRUST L.J. 369 (2009) (arguing that IP and other property should
be subject to similar treatment as far as refusal to deal is concerned); Brett M. Frischman & Spencer Weber
Waller, Revitalizing Essential Facilities, 75 ANTITRUST L.J. 1 (2008) (taking a more pro-enforcement view
of refusal to deal); Dennis W. Carlton, A General Analysis of Exclusionary Conduct and Refusal to Deal—
Why Aspen and Kodak Are Misguided, 68 ANTITRUST L.J. 659 (2001) (critiquing Supreme Court decisions
in Aspen and Kodak and describing limited circumstances under which refusal to deal could cause
consumer harm); Glen O. Robinson, On Refusal to Deal with Rivals, 87 CORNELL L. REV. 1177 (2002);
Robert Pitofsky et al., The Essential Facilities Doctrine Under U.S. Antitrust Law, 70 ANTITRUST L.J. 443
(2002); Spencer Weber Waller, Areeda, Epithets, and Essential Facilities, 2008 WIS. L. REV. 359 (2008);
Philip Areeda, Essential Facilities: An Epithet in Need of Limiting Principles, 58 ANTITRUST L.J. 841
(1989).
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technologies, which leaves society better off. Therefore, compulsory licensing
undermines the innovation incentives of the patentee, the putative licensees, and potential
future inventors. This innovation incentive argument presumes that any reduction in
patentee reward will reduce innovation incentives, and that the putative licensees possess
the technological capacity and commercial interest to innovate.
¶118
As has been repeatedly asserted in this Article, the former presumption is not true.
So long as the innovator is compensated for its innovation costs, including the
opportunity cost of innovation, innovation incentives will be preserved. Prominent
commentators and empirical evidence have affirmed this view. Hovenkamp has
advocated a nuanced and balanced stance on compulsory licensing:
One corollary of the principle that an IP right is simply property is that no special
deference is due to the IP laws when courts fashion remedies for proven antitrust
violations. For example, ordering compulsory licensing for a proven antitrust
violation is no different than fining a firm or ordering divestiture of a plant.
While we do not want to deter innovation, we do want to deter antitrust
violations either.200

In fact, it seems that patent lawyers and economists are less apprehensive about
compulsory licensing than antitrust lawyers themselves.201 Levin and his co-authors
concluded that compulsory licensing does not undermine innovation incentives in any
significant manner.202 Scherer found that “the substantial amount of evidence now
available suggests that compulsory patent licensing, judiciously confined to cases in
which patent-based monopoly power has been abused . . . would have little or no adverse
impact on the rate of technological progress . . . .”203 He further referred to specific
conversations with executives of Xerox, which had been subject to compulsory licensing
order in the 1970s, that refuted the popular belief that compulsory licensing had adversely
affected the firm’s R&D.204 Scherer goes so far as to conclude that “a massive antitrust
attack on business firms’ use of patents to monopolize markets or enhance profit returns
appears to have had negligible adverse consequences for the vigor of innovative activity
in the United States.”205
¶119
While this Article in no way advocates a massive attack on patent rights, this author
believes that imposing a duty to deal in limited instances will enhance social welfare.
Preservation of innovation incentives cannot be treated as a trump card in every refusal to
license case. It must be scrutinized with care to verify that those incentives will truly be
undermined if compulsory licensing is ordered. In particular, the applicability of the
innovation incentive argument depends on market conditions. There are at least two
circumstances under which the argument is unlikely to be valid: (1) aftermarkets; and, (2)
patent holdup.
200

Age of IP Expansion, supra note 16, at 238.
Burk & Lemley, supra note 20, at 1667; BAUMOL, supra note 6, at 215–16 (“if the price is right, it is
never most profitable for the owner of such technology to prevent others, even its most direct competitors,
from using it.”).
202
Levin et al., supra note 46, at 804.
203
F.M. SCHERER, INDUSTRIAL MARKET STRUCTURE AND ECONOMIC PERFORMANCE 456–57 (1980).
204
Antitrust, Efficiency, and Progress, supra note 25, at 1016.
205
Antitrust, Efficiency, and Progress, supra note 25, at 1018.
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A. Aftermarkets
¶120

As suggested earlier, the conventional argument against a duty to license presumes
that reduced patentee reward will undermine innovation incentives and that the spurned
rivals would have developed their own technologies. The extent to which the latter is
true depends on a variety of factors. Of particular interest to us is the consideration about
the level on which the rivals compete with the innovator. If the rivals do not compete in
the primary technology market and only compete in the aftermarkets in the provision of
derivative products or services, denying them access to the technology will be unlikely to
encourage innovation in the primary market. They will simply exit the aftermarkets
altogether. This is aptly illustrated by the Federal Circuit CSU v. Xerox case,206 and the
Ninth Circuit Image Technical Services v. Kodak case,207 which contains practically
identical facts as CSU. In those two cases, the request to deal was not made by Kodak’s
and Xerox’s rivals in the primary photocopying machine market, but by independent
service organizations (“ISOs”) that provide repair services for photocopying machines. It
is difficult to see how a rejection of a duty to deal would have spurred these ISOs to
develop their own photocopying machine technology to compete with Kodak and Xerox.
Compulsory licensing need not undermine the innovation incentives of the putative
licensees.
¶121
The patentee will no doubt focus on the first presumption and argue that profits
generated from the aftermarkets are necessary for it to recoup R&D investment. Unlike
the case for the second presumption about rivals’ innovation incentives, it does not seem
possible to come up with a categorical rule that will help the courts to distinguish valid
and invalid claims about the first presumption. The courts must instead scrutinize such
claims closely and not accept them at face value. The patentee should be required to
produce concrete evidence to substantiate the claim, including evidence that shows that
profits from the primary market is insufficient to cover the R&D costs.
¶122
For instance, this claim about aftermarket profits would have been unlikely to hold
in Image Technical Services, where Kodak had initially welcomed ISOs to provide
maintenance and repair services. It was only after the maintenance and repair market had
become lucrative and Kodak had lost an important maintenance contract with the state of
California that Kodak altered its prior policy of supplying parts to ISOs. 208 If Kodak had
considered profits from the aftermarket essential to its recoupment of R&D investment
from the start, it would have been unlikely to have adopted an open policy with the ISOs
initially. The Ninth Circuit eventually dismissed Kodak’s business justifications for the
refusal to deal on the ground that they were pre-textual, focusing on the subjective state
of mind of Kodak’s employees.209 This approach has been criticized as being
inconsistent with the modern antitrust focus on objective effects rather than subjective
intent.210 By focusing on Kodak’s employees’ subjective state of mind, the Ninth Circuit
was in fact attempting to verify Kodak’s innovation incentives argument. This focus is
206

203 F.3d 1322 (Fed. Cir. 2000).
Image Technical Serv., Inc. v. Eastman Kodak Co., 125 F.3d 1195 (9th Cir.1997).
208
125 F.3d at 1214.
209
Id. at 1218–20.
210
U.S. DEP’T OF JUSTICE & FEDERAL TRADE COMMISSION, ___SERIAL NUMBER ____, ANTITRUST
ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS: PROMOTING INNOVATION AND COMPETITION 5
(2007).
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clearly correct. The Ninth Circuit’s mistake was its reliance on the wrong type of
evidence. To determine the veracity of the innovation incentive argument, the Ninth
Circuit should not have relied on what Kodak’s employees thought, but whether profits
from the aftermarket were objectively necessary for Kodak to recoup its investment.
B. Patent Holdup
¶123

Patent holdup presents another situation in which imposing a duty to license may
be appropriate. Patent holdups are detrimental because they are likely to retard
cumulative innovation. They are also likely to provide a windfall to the patentee that is
above and beyond the profit necessary for the recoupment of innovation costs. The
previous two Sections explain the importance of cumulative innovation as a major source
of social benefits. Among the three models of cumulative innovation, patent holdup may
be a particularly serious problem in the trunk-branch and the anticommons models.211 As
discussed earlier, both situations present great potential for social welfare loss due to
patent holdups. Moreover, in the trunk-branch model, the Ramsey intuition means that
antitrust can restrict patent exploitation at the margin without causing much effect on
patentee reward. Cumulative innovation hence can be unlocked without substantial loss
of patentee rewards. Patent holdup is likely to provide a windfall to patentees.212 In the
event of a holdup, the negotiation usually takes place ex post after the innovation has
already been made and the R&D costs are sunk. The follow-on innovator is in a very
weak bargaining position to secure a surplus from the negotiation that will allow it to
recover those costs. It may need to accept any licensing arrangement that allows it to
cover its variable costs. In fact, Lemley and Shapiro argue that ex ante negotiation would
not significantly improve the follow-on innovator’s bargaining position.213 Cumulative
innovation will be deterred over the long haul.
¶124
Imposing a duty to license on opportunistic patentees may solve this problem. If
these patentees know that the courts may step in and mandate licensing at a reasonable
royalty rate,214 they will be induced to enter into negotiations with follow-on innovators
in good faith.215 The threat of compulsory licensing may become a default background
legal rule against which negotiations between initial and follow-on innovators take place.
The instances in which the courts need to intervene could be few.
211

The use of compulsory licensing to resolve holdup problems in anticommons situations has been
endorsed by Burk and Lemley. Burk & Lemley, supra note 29, at 1667. And the use of compulsory
licensing in the trunk-branch scenario is vividly illustrated in the Hybritech monoclonal antibodies case.
SCOTCHMER, supra note 12, at 154. The pioneering research on monoclonal antibodies was performed by
scientists George Koehler and Cesar Millstein on public funding. Hybritech, the patentee seeking to enjoin
others from utilizing the technology, only developed diagnostic kits. The innovation costs were likely to be
insubstantial compared to the initial research, while the harm to social welfare would be great due to the
importance of the technology.
212
Mark A. Lemley & Carl Shapiro, Patent Holdup and Royalty Stacking, 85 TEX. L. REV. 1991, 2008
(2007).
213
Id. at 2003–04.
214
The royalty of course needs to allow the initial innovator to recover its innovation costs.
215
The need for antitrust intervention in patent holdup cases has arguably receded after the Supreme
Court’s decision in eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006), in which the Court
unanimously overturned the longstanding presumption in patent law that a patentee is entitled to a
permanent injunction following a finding of infringement. This case has arguably reduced the possibility
of holdup behavior.
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C. Caveats
¶125

A number of caveats about the use of compulsory licensing are in order. First,
compulsory licensing should be rarely granted when the patentee itself practices the
patent. In such a case, there is a greater likelihood of reciprocity of interests, which
should encourage the parties to negotiate in good faith. There is thus a lower likelihood
of patent holdups. When one party to the negotiation has no need for the counterparty’s
technology, as in the case of patent trolls, opportunistic behavior and holdup are more
likely. Also, the fact that the patentee practices and commercializes the patent itself
means that it is more likely to compete with the putative compulsory licensee. As will be
elaborated below, compulsory licensing should be rarely granted when the patentee and
the licensee are competitors in the technology market. Antitrust should encourage
competition at the technology development level so that society can benefit from
competing technological offers.
¶126
Second, the courts should be cautious about imposing compulsory licensing when
the putative licensee competes directly with the patentee in the primary technology
market. In relation to this point, it is worthwhile to evaluate Professor Daniel Crane’s
objection to imposing a duty to deal with respect to intellectual property. Crane
distinguishes the denial of injunctive relief under patent law from antitrust imposition of
a duty to deal, rejecting the latter while endorsing the former. The crux of his objection
is that the latter requires the monopolist patentee positively to assist rivals in the
acquisition and deployment of the technology.216 This objection raises some fundamental
questions about the relationship between compulsory licensing and innovation incentives.
¶127
This author agrees with Crane that a patentee should not be required to provide
positive assistance to its rivals if doing so will impair innovation incentives, both on the
part of the patentee and the putative licensees (the incentive effect on future potential
inventors presumably is a derivative of the effect on the patentee). The purpose of
antitrust law is to encourage competition in technology and innovation. Having multiple
firms pursue alternative routes to technological development is likely to be beneficial to
society in the long run. However, requiring a patentee to provide positive assistance
would only reduce innovation incentives if the putative licensee competes with the
patentee in the technology market; i.e., they offer competing technologies or products in
the primary market. It will have negligible impact on overall innovation incentives in the
case of aftermarket competitors.217 ISOs and other aftermarket operators are ill-equipped
to contribute technological alternatives in the primary market. In fact, in most cases, the
aftermarket operators do not license the technology in order to produce a competing
product. They obtain a license so that they can sell or use products manufactured by the
patentee. There is no concern about positive assistance to rivals that will undermine their
innovation incentives.
¶128
The same argument applies to follow-on innovators in the trunk-branch case as
well as the anticommons case. To the extent that these follow-on innovators do not
compete with the initial innovator in the development of basic scientific research or
216

Crane, supra note 1, at 97.
In the case where the putative licensee competes with the patentee in both the primary technology
market and the aftermarket, the overriding need to preserve innovation incentives in the primary market
means that compulsory licensing should be disfavored.
217
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research tools, compulsory licensing does not undermine innovation incentives on the
part of these follow-on innovators. The incentives of the initial innovator of course still
need to be considered, but those will be preserved so long as private benefits of
innovation cover innovation costs.
¶129
Third, a unilateral refusal to license claim should only be upheld if imposing a duty
to license would substantially improve competition or promote innovation. Compulsory
licensing may bring two main benefits: (1) greater competition in a market where
competition has been hitherto precluded by patent protection, and (2) facilitation of
innovation that builds upon the patented technology. If neither benefit will materialize as
a result of compulsory licensing, there would be few good reasons to alter the patentee’s
reward, regardless of its impact on innovation incentives. If the market at issue is already
highly competitive, consumers will have little to gain from the competition introduced by
compulsory licensing. While some rivals may prefer to gain access to the patented
technology to increase their competitive advantage, compulsory licensing in such a case
would only result in wealth transfer between competitors with little attendant gains in
consumer welfare. This is clearly an insufficient justification for antitrust intervention.
Similarly, if innovation will not be promoted by compulsory licensing, such as by
overcoming patent holdup, compulsory licensing should not be imposed.
D. Case Law
¶130

The proposed framework to unilateral refusal to license cases is largely consistent
with the outcome, if not the analytical approach, of the existing case law. 218 Two leading
cases, the Ninth Circuit Image Technical Services v. Kodak case and the In re
Independent Service Organizations Antitrust Litigation case, both involved ISOs of
photocopying machines that did not produce photocopying machines or engage in
research in photocopying technology. The ISOs did not compete with the photocopying
machine manufacturers in the primary market. The two courts reached divergent
outcomes with essentially the same facts. The Ninth Circuit upheld the ISOs’ unilateral
refusal to license claim, while the Federal Circuit did not. It is suggested that despite its
misplaced focus on the subjective intent of Kodak’s employees, the Ninth Circuit’s result
is more consistent with an approach to the patent-antitrust interface that strikes a balance
between preserving competition and safeguarding innovation incentives. With its
expansive holding that absent a fraudulently obtained patent, sham enforcement action or
illegal tying, a patentee is free to refuse to license its intellectual property, the Federal
Circuit displayed too much deference to the patentee. Apart from these enumerated
circumstances, there are situations in which compulsory licensing may be imposed to
preserve or promote competition and innovation without impairing innovation incentives.
There was no evidence in that case that Xerox relied on the profits from the maintenance
market to recoup its R&D costs. Therefore, giving the ISOs access to Xerox’s parts was
unlikely to have reduced the manufacturer’s innovation incentives. Meanwhile, there
was evidence in both cases that requiring Kodak and Xerox to deal with rivals would
218

See, e.g., Image Technical Serv. v. Eastman Kodak Co., 125 F.3d 1195 (9th Cir. 1997); In re Indep.
Serv. Orgs. Antitrust Litig., 203 F.3d 1322 (Fed Cir. 2000), Data Gen. Corp. v. Grumman Sys. Support
Corp., 36 F.3d 1147 (1st Cir. 1994); SCM Corp. v. Xerox Corp., 645 F.2d 1195 (2d Cir. 1981); Intergraph
Corp. v. Intel Corp., 195 F.3d 1346 (Fed Cir. 1999).
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have substantially improved competition in the maintenance market: Kodak held at least
80% of the maintenance market. And there was evidence that the unavailability of spare
parts had made it increasingly difficult for the ISOs to compete with Xerox. There was
also evidence in Kodak that many consumers actually preferred services provided by the
ISOs. Gains in consumer welfare in both cases from compulsory licensing would have
been substantial. With little impact on the patentee’s innovation incentives and
substantial gains in consumer welfare, compulsory licensing should have been imposed in
both cases.
¶131
In SCM Corp. v. Xerox Corp., the Second Circuit refused to require Xerox to
license its patent on plain paper copier to a competitor to allow the latter to compete with
Xerox in the copier market.219 The court’s language was very much in favor of patentees
and has been interpreted as creating a per se legality rule for unilateral refusal to license a
patent.220 While a per se legality approach (if the Second Circuit did in fact intend the
case to be interpreted as such) would clearly be too permissive, this author believes that
the court reached the correct outcome in that case. The reason is simply that the plaintiff
was a direct competitor of Xerox’s in the photocopying machine market. Imposing
compulsory licensing would have directly affected Xerox’s patentee reward. It would
have also reduced SCM’s incentive to engage in its own research, which it presumably
would have been prepared to do as it had planned to compete in the photocopying
machine market.
¶132
Another leading unilateral refusal to license case is Data General Corp. v.
Grumman Systems Support Corp.,221 where the First Circuit rejected Grumman’s claim
that Data General illegally maintained its monopoly in the market for servicing Data
General’s computers by refusing to license its diagnostic software. Similar to the ISOs in
Image Technical Services and In re Independent Service Organizations Antitrust
Litigation, Grumman provided repair services for Data General’s computers. This may
suggest that the First Circuit should have upheld the unilateral refusal to license claim
and ordered Data General to license its diagnostic software. The crucial difference
between this case and the two photocopying machine cases is that in those cases, the
spare parts were simply part of the photocopying machines that did not require
independent effort to invent. The diagnostic software in Data General was itself a
separate invention that required investments on the part of the computer maker.
Therefore, at issue are two inventions, the computer and the diagnostic software.
Allowing Grumman to gain access to the software may not have had much impact on the
R&D for the computer, but it would most probably have undermined Data General’s
research effort in the software. Therefore, the First Circuit’s decision was consistent with
the framework proposed in this Section.
¶133
Lastly, in Intergraph v. Intel, the Federal Circuit rejected a unilateral refusal to deal
claim by Intergraph, the owner of a technology known as “Clipper,” which Intel
incorporated into its microprocessor chips. Intel and Intergraph did not compete with
each other in any relevant market. Intergraph competed in the market for graphics
workstations, which according to the court was already highly competitive. Intel had
219

SCM Corp., 645 F.2d at 1195.
Michael A. Carrier, Refusals to License Intellectual Property After Trinko, 55 DEPAUL L. REV. 1191
(2006).
221
36 F.3d at 1147.
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been providing Intergraph technical assistance and privileged access to proprietary
information, pre-release products, and allocation of new products. Intergraph’s claim
arose when Intel terminated their technical assistance and access to information services
following repeated failure to settle a patent infringement suit between the two parties.
While the technical assistance and access to information no doubt gave Intergraph an
important commercial advantage in the graphics workstation market, there was no
evidence that Intergraph needed the information and assistance for its own R&D. The
resulting benefit in innovation from compulsory licensing would have been minimal.
Nor would consumers stand to gain much from it; the market in which Intergraph
competed was already highly competitive. The Federal Circuit thus reached the correct
decision by rejecting Intergraph’s claim.
¶134
The proposed approach to unilateral refusal to license is also consistent with the
admonitions by Justice Scalia, writing for the majority in Trinko,222 about the harm of
judicial imposition of a duty to deal. One of the gravest concerns expressed by Justice
Scalia about imposing a duty to deal was that it would discourage firms from making
future investments in physical facilities.223 The proposed approach specifically takes that
concern into account by requiring that the innovator be fully compensated for its
innovation costs. The incentive to invest would not be impaired, as feared by Justice
Scalia.
¶135
Furthermore, Justice Scalia believes that “[e]nforced sharing also requires antitrust
courts to act as central planners, identifying the proper price, quantity, and other terms of
dealing[.]”224 That concern may have been valid in the context of Trinko, which involved
a heavily regulated industry where the identification of the parameters of sharing is more
akin to the kind of rate-setting activities that are usually undertaken by the regulatory
agencies. It has little relevance for the unilateral refusal to license cases. The federal
courts regularly engage in royalty setting in patent damages determination. The kind of
“rate-setting” activity required in compulsory licensing is not unfamiliar to the courts and
should not raise any special concerns. Moreover, at least in the case of patent holdup,
once the threat of compulsory licensing becomes a real one, judicial intervention will
only be necessary if negotiation breaks down, which should be rare once judicial
imposition of a duty to deal becomes a distinct possibility.
¶136
Justice Scalia further argues that enforced sharing encourages collusion. 225 While
that is no doubt a valid concern, policing against collusion is the bread-and-butter of
antitrust agencies. There is no reason to believe that the agencies will be uniquely
incapable of detecting collusion among technology firms. Joint ventures may facilitate
collusion, and that has not prevented the agencies from approving them in most instances.

222

Verizon Comm. v. Law Offices of Curtis V. Trinko, LLP, 540 U.S. 398, 124 S.Ct. 872 (2004).
Whether the courts will take the same approach to both unilateral refusal to deal regarding a physical
property and unilateral refusal to license an intellectual property is still an unsettled question. Shelanski,
supra note 199, at 373–78. This author believes that physical property should be accorded no less
deference than intellectual property as far as unilateral refusal to deal is concerned. Given that the Supreme
Court has not ruled on the appropriate standard for unilateral refusal to license intellectual property, and the
lower courts have adopted a divergent range of approaches, the ensuing discussion will proceed under the
assumption that the framework set out in Trinko applies to unilateral refusal to license patent rights.
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Trinko, 540 U.S. at 407–08.
224
Id. at 408.
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Id.

438

Vol. 11:5]

Thomas Cheng

The likelihood that collusion may materialize in compulsory licensing situations is
arguably lower than that within joint ventures, given the involuntary nature of the former.
V. CONCLUSION
¶137

This Article calls for the restoration of a full and more probing consideration of
innovation incentives in the patent-antitrust interface. A full consideration should not
solely focus on the incentives of the original innovator, but those of the follow-on
innovators as well. This is important because cumulative innovation creates substantial
social benefits. The technological development process does not end after the initial
innovation. Subsequent innovations will build on it and create more value for consumers
and society. A probing consideration should not accept any innovation-based defenses of
patent exploitation practices at face value, as some antitrust courts seem to have done.
Instead, it should ask searching questions about the extent to which a patentee depends on
patentee reward for innovation incentives. There should be a return to full recognition
and application of the fundamental premise of the patent system that innovators will
continue to produce innovations as long as their innovation costs are fully compensated.
While most courts are fully aware of this premise, they seem to overlook it as soon as
they turn their attention to a concrete case and become singularly focused on preservation
of patentee reward. Once this premise is again fully recognized, the courts will realize
that there is considerable room to advance consumer welfare without impairing
innovation incentives. Antitrust need not show the same degree of deference to patent
policy as has often been advocated.
¶138
This, however, does not mean that antitrust should interfere with the patent system
on a substantial scale. To the extent that the specific policy issues presented by the
patent-antitrust interface are already resolved internally within the patent system, antitrust
should wisely abstain from intervention. There are signs that the patent system is moving
in the right direction and beginning to curtail expansive patent rights. But where antitrust
can play a useful role, the courts should not shy away from it simply because dynamic
efficiency arguments are by their nature more difficult to evaluate and rebut. It is the job
of the antitrust courts to subject every pro-competitive justification presented to them to
close scrutiny. No argument should be allowed to become a trump card; not even one
based on something as important to economic growth as innovation. The antitrust courts
have underestimated their ability to assess dynamic efficiency arguments. Once the
courts recognize the diversity of innovations and acquire a fuller understanding of the
various attributes of innovation, the courts will be in a better position to assess these
arguments. This Article has only illustrated the application of this new awareness in the
context of the unilateral refusal to license a patent. The implication of the proposed
approach in other areas of the patent-antitrust interface remains to be explored. The hope
is that, in time, a more balanced approach to the patent-antitrust interface with full and
fair consideration of dynamic efficiency arguments will emerge.
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